P. 21:  Consistent proof that eating less is scientifically proven to increase lifespan extension: 

JAMA. 2004 Mar 10;291(10): 1226-30. Michels KB et al.

P. 21: Medical studies consistently proving that eating less increases lifespan: 

Microsc Res Tech. 2002 Nov 15;59(4): 335-8. Lane MA et al.

P. 21: Caloric reduction improves insulin sensitivity and decreases midsection fat: 

Toxicol Sci. 1999 Dec;52(2 Suppl): 49-55. Cefalu WT et al.; J Gerontol A Biol Sci Med Sci. 2004 Oct;59(10): 1007-14. Cefalu WT et al.

P. 21: Caloric reduction reduces LDL cholesterol, triglycerides and weight: 

Free Radic Biol Med. 2007 Mar 1;42(5): 665-74. Johnson JB et al.

P. 22: Calorie reduction lowers rate of mitochondrial free-radical cell formation:

Int J Biochem Cell Biol. 2002 Nov;34(11):1340-54. Merry BJ et al.

P. 22: Calorie reduction lowers marker of oxidative stress: 

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52): 19908-12. Hyun DH et al.

P. 22: Calorie reduction decreases TNF alpha and increases natural antioxidants: 

Free Radic Biol Med. 2007 Mar 1;42(5): 665-74. Johnson JB et al.

P. 22: Calorie reduction benefits breast cancer: 

JAMA. 2004 Mar 10;291(10): 1226-30. Michels KB.; Exp Biol Med (Maywood). 2007 Jan;232(1): 70-80. Cleary MP et al.; Interdiscip Top Gerontol. 2007;35: 176-92. Klebanov S.

P. 22: Calorie reduction protects genome by increasing repair and decreasing mutation: 

J Nutr Health Aging. 1999;3(2): 102-10. Raffoul JJ et al.

P. 22: Calorie reduction produces new neurons, increases apoptosis and helps DNA repair itself: 

Ann N Y Acad Sci. 2004 Jun;1019: 96-105. Hiona A et al.

P. 22: Calorie reduction decreases brain inflammation: 

Interdiscip Top Gerontol. 2007;35: 83-97. Morgan TE et al.

P. 22: Calorie reduction decreases oxidative stress in brain: 

Proc Natll Acad Sci U S A. 2006 Dec 26;103(52): 19908-12. Hyun DH et al.

P. 22: Calorie reduction decreases brain toxicity and increases memory consolidation: 

Brain Res Mol Brain Res. 2000 May 31;78(1-2): 154-62. Eckles-Smith K et al.; Neuroreport. 2005 Jul 13;16(10): 1129-33. Hashimoto T et al.

P. 22: 50% calorie reduction in obese women improves word recall: 

Int J Obes Relat Metab Disord. 1997 Jan;21(1): 14-21. Kretsch MJ et al.

P. 23: Caloric reduction programs show promise in reducing incidence of Alzheimer's: 

Interdiscip Top Gerontol. 2007;35: 159-75. Pasinetti GM et al.

P. 23: Bone loss with caloric reduction is mitigated if accompanied by physical activity: 

Arch Intern Med. 2006 Dec 11-25;166(22): 2502-10. Villareal DT et al.

P. 23: Caloric reduction prevents muscle fiber loss: 

FASEB J. 2004 Mar;18(3): 580-1. McKiernan SH et al.

P. 23: Caloric reduction preserves aerobic function in aging muscle: 

FASEB J. 2005 Aug;19(10): 1320-2. Hepple RT et al.

P. 23: Caloric reduction improves skin disease: 

J Physiol Anthropol Appl Human Sci. 2003 Sep;22(5): 237-40. Nakamura H et al.; J Physiol Antropol Appl Human Sci. 2000 Sep;19(5): 225-8. Kouda K et al.

P. 24: Caloric reduction into obese pregnant women has no negative effects for the fetus: 

J Nutr. 1984 Dec;114(12): 2247-55. Reynolds LK et al.

P. 24: Calorie reduction programs maintain reproductive hormones and menstrual cycles

Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46. Mattison JA et al.

P. 24: In healthy, lean females, inappropriate calorie reduction reduces T3 levels: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 3232-5. Fontana L et al.

P. 24-25: HGH increases during fasting: 

Growth Horm IGF Res. 2002 Aug;12(4): 198-207. Norrelund H et al.

P. 25: Dieting increases HGH levels in obese girls: 

J Clin Endocrinol Metab. 2002 Apr;87(4): 1885-93. Kasa-Vubu JZ et al.

P. 25: Age-related Melatonin decline arrested by 30% calorie reduction: 

J Clin Endocrinol Metab. 2001 Jul;86(7): 3292-5. Roth GS et al. ; Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46. Mattison JA et al.

P. 25: Long-term calorie reduction slows age-associated DHEA reductions: 

J Clin Endocrinol Metab. 2001 Jul;86(7): 3292-5. Roth GS. et al.

P. 25: Calorie reduction increases adiponectin while decreasing fat: 

Obes Surg. 2006 Nov;16(11): 1425-32. Kotidis EV et al.

P. 26: Caloric reduction mitigates kidney lesions: 

Gerontology. 2005 Mar-Apr;51(2): 83-93. Loupal G et al.

P. 26: Calorie reduction decreases liver faty size 40%: 

Obes Surg. 2006 Jun;16(6): 697-701. Lewis MC et al.

P. 26: Calorie reduction improves retina health: 

Bio Chem Biophys Res Commun. 2003 Sep 19;309(2): 457-63. Li D et al.

P. 26: Calorie reduction slows cataracts development: 

Exp Eye Res. 2004 Jan;78(1): 151-8. Wang K et al.

P. 26: Calorie reduction delays onset of glaucoma: 

J Glaucoma. 1997 Feb;6(1): 18-22. Li Y et al.

P. 26: 30-year studies on non-human primates indicate universal affect across species with calorie reduction: 

Microsc Res Tech. 2002 Nov 15;59(4): 335-8. Lane MA et al

P. 26: Reducing calories every other day offers benefits:

 Med Hypotheses. 2006;67(2): 209-11. Johnson JB et al.

P. 33: Ghrelin causes you to feel hungry and increase overall food intake: 

Diabetes. 2006 Nov;55(11): 3038-46. Chelikani PK et al.

P. 33: Ghrelin moves food out of stomach quickly: 

J Clin Endocrinol Metab. 2006 Sep;91(9): 3296-302. Levin F et al.

P. 33: Eating protein suppresses ghrelin: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2913-9. Bowen J.

P. 34: Protein increases GLP-1, decreasing appetite: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2913-9. Bowen J et al.

P. 40: R-Lipoic Acid reduces body weight and improves insulin sensitivity: 

Hormones (Athens). 2006 Oct-Dec;5(4): 251-8. Kamenova P.

P. 40: R-Lipoic Acid can be effective in controlling neurological damage: 

Invest Ophthalmol Vis Sci. 2006 Sep;47(9): 4077-82. Roberts R et al.; Diabetes Care. 2006 Nov;29(11): 2365-70. Ziegler D et al.

P. 40: R-Lipoic Acid can decrease glycation: 

Pharmazie. 2005 Oct;60(10): 772-5. Thirunavukkarasu V et al.

P. 40: Chromium is efficient in treating insulin resistance: 

Diabetes Care. 2006 Dec;29(12): 2764-5. Martin J et al.; Folia Med. (Plovdiv). 2005;47(3-4): 59-62. Vladeva SV et al.; Mutat Res. 2006 Nov 7;610(1-2): 93-100. Pattar GR et al.

P. 40: Cinnamon extract has anti-diabetic potency and improves insulin sensitivity: 

Eur J Clin Invest. 2006 May;36(5): 340-4. Mang B et al.; Phytomedicine. 2007 Jan;14(1): 15-22. Subash Babu P et al.

P. 40: Vanadium may improve diabetic condition: 

Arch Biochem Biophys. 2005 Aug 15;440(2): 158-64. Mehdi MZ et al.; J Vet Sci. 2006 Dec;7(4): 391-5. Kim JM et al.; Clin Calcium. 2005 Jan;15(1): 49-57. Sakurai H.

P. 46: Moderately strenuous or small amount of activity will delay death: 

Scand J Public Health. 2006;34(5):480-7. Carlsson S et al.

P. 46: Cardiovascular exercise and weight training prevent arterial sclerosis: 

Sports Med. 2003;33(14):1013-35. Maiorana A et al.

P. 46: Exercise decreases frequency of breast, colon, prostate and lung cancers: 

Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):11-21. Kruk J et al.; Cancer epidemiol Biomarkers Prev. 2007 Feb;16(2):236-43. Sprague BL et al.

P. 47: Exercise improves antioxidant function: 

Life Sci. 2006 May 22;78(26):3074-81. Brites F et al.

P. 47: Activity is helpful for depression and overall well being: 

Pediatrics. 2006 Nov;118(5):2126-34. Daley AJ et al.; J Psychiatr Pract. 2006 Jul;12(4):205-13. Trivedi MH et al.

P. 47: Acute exercise reduces panic disorder: 

J Affect Disord. 2007 Aug 27; Esquivel G. et al.

P. 47: Cardiovascular conditioning improves memory: 

Am J Geriatr Psychiatry. 2006 June;14(6):538-45. Small GW et al.

P. 47: Strength training improves memory: 

J Aging Phys Act. 2006 Jan;14(1):59-73. Lachman ME et al.

P. 48: Very challenging exercise can lead to oxidative stress and DNA damage: 

Redox Rep. 2005;10(6):325-31. Briviba K et al.

P. 49: The older we are, we get more prone to oxidative damage: 

Ann N Y Acad Sci. 2001 Apr;928:236-47. Ji LL.

P. 51: Muscular fatigue may indicate oxidative stress and over training: 

Sports Med. 2006;36(4):327-58. Finaud J et al.

P. 51: Exercise decrease IVF outcomoe: 

Obstet Gynecol. 2006 Oct;108(4):938-45. Morris SN et al.

P. 52: L-Argenin before exercise is beneficial: 

Int J Sports Med. 2002 Aug;23(6):403-7. Schaefer A et al.

P. 52: D-Ribose can improve physical and cardio performance: 

Lancet. 1992 Aug 29;340(8818):507-10. Pliml W et al.

P. 52: L-Carnitine improves exercise tolerance: 

Am J Kidney Dis. 2003 Apr;41(4 Suppl 4):S35-43. Pauly DF et al.

P. 52: L-Carnitne benefits training, competition and recovery: 

Nutrition. 2004 Jul-Aug;20(7-8):709-15. Karlic H et al.

P. 53: L-Glutamine promotes muscle glycogen storage: 

J Appl Physiol. 1999 Jun;86(6):1770-7. Bowtell JL et al.

P. 53: L-Glutamine is important fuel for immune system cells: 

Nutrition. 2002 May;18(5):371-5. Castell LM.

P. 53: Supplementing L-Glutamine decreases incidence of illness in endurance athletes: 

Nutrition. 2002 May;18(5):371-5. Castell LM.

P. 53: L-Glutamine improves sugar balance before and after exercise: 

J Appl Physiol. 2005 Nov;99(5):1858-65. Iwashita S et al.

P. 56: Eating disorders and sexuality: 

Int J Eat Disord. 1996 Mar;19(2): 109-18. Wiederman MW et al.

P. 58: Men are more attracted to women when estrogen levels rise: 

Proc Biol Sci. 2006 Jan 22;273(1583): 135-40. Smith MJ et al.

P. 68: Negative impact of Women’s Health Initiative: 

Ob Gyn News October 1, 2006. Dixon BK.

P. 70: Premarin increases inflammation: 

Maturitas. 2003 Dec 10;46(4):245-53. Yilmazer M et al.; Atherosclerosis. 2006 Dec;189(2):436-42. Sumino H et al.; Menopause. 2005 Sep-Oct;12(5):552-8. Vitale C et al.; Atherosclerosis. 2006 Apr;185(2):347-52. Hu P et al.

P. 70: Bioidentical estradiol in cream form decreases inflammation: 

Gynecol Obstet Mex. 2006 Mar;74(3):133-8. Saucedo Garcia R et al.; Cytokine. 2005 Aug;31(4):251-7 Liu H et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. WangY et al.; Rheumatol Int. 2003 Nov;23(6):282-8. Lee YJ et al.

P. 70: Bioidentical estradiol does not increase CRP: 

Maturitas. 2005 Oct 16;52(2):111-8. Eilertsen AL et al.; Menopause. 2006 Sep-Oct;13(5):840-5. Rachon D et al.; Maturitas. 2003 Dec 10;46(4):245-53. Yilmazer M et al.

P. 70: Premarin and bioidential estradio in capsule/pill form increase CRP: 

Maturitas. 2005 Oct 16;52(2):111-8. Eilertsen AL et al.

P. 71: Premarin increases body fat and decreases lean body mass: 

Adv Ther. 2006 Mar-Apr;23(2):263-73. Delibasi T et al.

P. 71: Bioidentical estradiol decreases body fat: 

Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1251-63. Asarian L et al.; Psychol Med. 2006 Oct 12;:1-11. Edler C et al.; Fertil Steril. 2006 Dec;86(6)1669. Micheline CC et al

P. 71: Bioidentical estradiol promotes muscle growth and regeneration: 

J Appl Physiol. 2006 Jun;100(6):2012-23. McClung JM et al.

P. 71: Premarin increases cardiovascular events: 

Arch Intern Med. 2006 Feb 27;166(4):399-404. Lemaitre RN et al.; Atherosclerosis. 2006 Apr;185(2):347-52. Hu P et al.

P. 71: Premarin increases atherosclerotic vascular disease: 

Hum Reprod. 2006 Oct;21(10):2715-20. Ho JY et al.

P. 71: Premarin increases venous thrombosis: 

Arch Intern Med. 2006 Apr;166((7):772-80 Curb JD et al.

P. 71: Bioidentical estradiol cream does not increase blood clots or venous thrombosis: 

Circulation. 2007 Feb 20;115(7):840-5. Canonico M et al.

P. 71: Bioidentical estradiol protects the heart: 

Menopause. 2006 Jul-Aug;13(4):643-50. Zegura B et al.; Basic Res Cardiol. 2006 Jul 4; Beer S et al.; Menopause. 2001 Jul-Aug:8(4):252-8. Ventura P et al.; Ob Gyn News April 15 2005. Wildman RP. Page 28.; Fertil Steril. 2004:82:391-7. Mack WJ et al.; Ann NY Acad Sci. 1990;592:193-203. Stampfer M et al.; Hypertens Res. 2005 Jul;28(7):579-84. Sumino H et al.

P. 71: Premarin Increases systemic lupus erythematosus flares: 

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):953-62. Buyon JP et al

P. 71: Premarin increases migraines: 

Maturitas. 2001 Apr 20;38(2):157-63. Nappi RE et al.

P. 71: Bioidentical estradiol is effective treatment for migraine: 

New Advance In Headache Research 4th add London-Smith Gordon 1999:129. Predalier A et al.; Neurology. 1972 Apr;22(4):355-65. Somerville BW.; Neurology. 2006 Sep 13: Macgregor EA et al.; Headache 2006 Oct;46 Suppl 2:S49-54. Zacur HA.

P. 71: Premarin decreases co-enzyme Q10 and vitamin gamma-E: 

Biofactors. 2005;25(1-4):61-6. Palan PR et al.

P. 72: Premarin increases stress incontinence: 

JAMA. 2005 Feb 23;293(8):935-48. Hendrix SL et al.; Menopause. 2005 Mar;12(2):160-4. Goldstein SR et al.

P. 72: Premarin increases Dry Eye Syndrome:

Gynecol Endocrinol. 2006 Sep;22(9):501-5. Uncu G et al

P. 72: Bioidentical estrogen decreases Dry Eye Syndrome:

Gynecol Endocrinol. 2005 May;20(5):289-98. Versura P et al

P. 73: Bioidentical progesterone protects from breast cancer: 

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10506-11. Nilsen J.; J Steroid Biochem Mol Biol. 2001 Aug;78(2):185-91. McDonnel AC et al.; Clin Cancer Res. 2001 Sep;7(9):2880-6. Lin VC et al.; Am J Epidemiol. 1981;114(2):209-17 Cowan LD.; Int J Cancer. 2005 Apr10;114(3):448-54. Fournier A.; Pathol Biol. 1987;35:1081-86. Mauvais-Jarvis P.; Ann NY Acad Sci. 1986;464:152-67. Mauvais-Jarvis P.; Cancer Detect Prev. 1999;23:290-298. Plu-Bureau G.; Climacteric.2002;5:332-40. Lignieres B.; Breast Cancer Res Treat. 2006 Jul 14; Wood CE.; J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR.; Breast J. 2006 Nov;12(6):518-525. Kontos M.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):241-9. Mendelson CR et al.

P. 73: Provera and other chemicalize progestin promotes breast cancer: 

Cancer. 2003;97(6):1387. Olsson el al.; Oncogene. 2006 Dec 14;25(59):7723-39. Salatino M et al.; Breast Cancer Res Treat. 2006 Jul 14; Wood CE et al; Horm Metab Res. 2005 Aug;37(8):468-73. Seeger H et al.; BMC Cancer. 2006 Oct 18;6:246. Eigeliene N et al.; Endocrinology. 2005 Nov;146(11):4917-25. Saitoh M et al.; J National Cancer Institute. 2000;92(4):328-32. Ross RK et al; Int J Cancer. 1999;81(3):339. Magnusson C et al.; FASEB. 2007 Aug;21(10):2285-93. Birrell SN et al

P. 73: Bioidentical progesterone does not promote diabetes: 

Euro J Endo.1999;140(3):215-223. Cucinelli F et al.; Exp Physiol. 2007 Jan;92(1):241-9. Ordonez et al.

P. 73: Provera increases diabetes: Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.; Am J Obstet Gynecol. 2006 Feb;194(2):355-61. Goodrow GJ et al.; Arch Intern Med. 2001;161:1766-1771. Kim C. et al

P. 73: Bioidentical progesterone builds bone: 

Endocr Res. 2003 Nov;29(4):483-501. Liang M et al.; Di Yi Jun Yi Da Xue Xue Bao. 2001;21(12):929-931. Zhang P et al.; Calcif Tissue Int. 2002 Oct;71(4):329-34. Luo XH et al.; J Tongji Med Univ. 2000;20(1):59-62. Chen L. et al.; Zhonghua Fu chan Ke Za Zhi. 1997 Sep;32(9):538-40. Chen L et al.; Zhonghua Fu chan Ke Za Zhi. 2004 Apr;39(4):250-3. Liang M et al.; Fertil Steril. 2006 Nov;86(5):1466-74. Clark MK et al.; Arch Pediatir Adolesc Med. 2005 feb;159(2):139-44. Scholes D et al.

P. 73: Provera cause bone loss: 

Menopause 2001;8(1):10-16. Montplaisir J et al.; Fertil Steril. 2004 Dec;82(6):1580-6 Clark MK et al.

P. 73: Bioidentical progesterone protects the heart: 

Arterio Thromb Vas Biol. 2001;21:243-8. Otsuki M et al.; Arterio Thromb Vas boil. 2004;24:955-961. Hermsmeyer RK et al.; J A Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.

P. 73: Provera destrucitive to the cardio vascular system and the heart: 

Circulation. 2002 Sep 24;106(13):1646-51. Sorensen MB et al.; J Am Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Hypertension. 2006 Nov;48(5):994-1001. Arias-Loza PA et al.; J Am Coll Cardiol. 1994 Dec;24(7):1757-61. Williams JK et al.; Steroids. 2006 Sep;71(9):834-42. Pederses DH et al.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Aterioscler Thromb Vasc. Biol. 1998 Jul;18(7):1164-71. Register TC et al.; Circulation. 2001 Oct 9;104(15)):1773-8. Wakatsuki A et al.

P. 73: Bioidentical progesterone promotes better sleep: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Menopause. 2001;8(1):10-16. Montplaisir J et al.; Curr Med Chem. 2006;13(29):3575-82. Andersen ML et al.

P. 73: Provera decrease sleep quality: 

Jpn J Psychiatry Neurol. 1987 Jun;41(2):261-7. Kotorii T et al.

P. 73: Provera negative affects on the immune system: 

Virology. 2006 Aug 15;352(1):169-77. Trunova N et al.

P. 73: Provera is destructive to the brain: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J et al.

P. 73: Provera is known to induce neuron-degenerative diseases: 

Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):205-13. Pluchino N et al.; Proc Natl Acad Sci USA. 2003 Sep 2;100(18):10506-11. Nilsen J et al.; J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.

P. 73: Bioidentical progesterone protects neurological system: 

J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; J Neurotrauma. 2006 Feb;23(2):181-92. Labombarda F et al.; J Neuroendocrinol. 2004 Jan;161(1):58-63. Ciriza I et al.; Neuro Endocrinol Lett. 2006 Oct;27(5):675-8. Muller E et al.; Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al.; J Mol Neurosci. 2006;28(1):3-15. De Nicola AF et al.; J Neurosci Res. 2007 Aug 15;85(11):2441-9. Kaur P et al.; Exp Neurol. 2007 Feb;203(2):406-14. Gonzalez Deniselle MC et al.

P. 73: Provera promotes aggressive feelings: 

Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al.

P. 73: Provera promotes anxiety and depression: 

J Women’s Health Gend Base Med. 2000 May;9(4):381-387. Fitzpatrick LA et al.

P. 74: Provera increases seizures: 

Epilepsia. 2006 Sep;47(9):1447-51. Harden CL et al.

P. 74: Bioidentical progesterone increases GABA and allopregnenolone and is a brain calmer: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D.; Brain Res. 1995 May 22;680(1-2):135-41. Picazo O et al.; J Women’s Health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.; J Neuroendocrinol. 2004 Jan;161(1):58-63. Ciriza I et al.

P. 74: Provera negatively affects hearing: 

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14246-9. Guimaraes P et al.

P. 73: Bioidentical progesterone has a positive affect on hearing: 

Neuropsychologia. 2002;40(8):1293-9. Alexander GM et al.

P.74: Provera may promote allergy, IBS and IC by increasing mast cells: 

Hum Reprod. 2000 Jan;15(1):123-30. Vincent AJ et al.

P. 74 Bioidentical progesterone decreases mast cells: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.

P. 74 Bioidentical progesterone decreases water retention: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al.

P. 74: The scientific community is aware of the significant dangers associated with provera use: 

Menopause. 2001;8(1):10-16. Montplaisir J et al.; Cancer. 2003;97(6):1387-92. Olsson HL et al.; J A Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.; Epilepsia. 2006 Sep;47(9):1447-51. Harden CL et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14246-9. Guimaraes P et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Oncogene. 2006 Dec 14;25(59):7723-39. Salatino M et al.; Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J et al.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):205-13. Pluchino N et al.; Hypertension. 2006 Nov;48(5):994-1001. Arias-Loza PA et al.; Fertil Steril. 2004 Dec;82(6):1580-6. Clark MK et al.; Fertil Steril. 2006 Nov;86(5):1466-74. Clark MK et al.; Horm Metab Res. 2005 Aug;37(8):468-73. Seeger H et al.; BMC Cancer. 2006 Oct 18;6:246. Eigeliene N et al.; Endocrinology. 2005 Nov;146(11):4917-25. Saitoh M et al.; Hum Reprod. 2000 Jan;15(1):123-30. Vincent AJ et al.; J National Cancer Institute. 2000 Feb 16;92(4):328-32. Ross RK et al.; Int J Cancer. 1999;81(3):339. Magnusson C.; Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH.; Ann Clinic Biochem. 1996 May;33(Pt 3):187-9. Malik KJ et al.; Sex Transm Dis. 2004 Sep;31(9):561-7. Morrison CS et at.; Arch Pediatr Adolesc Med. 2005 Feb;159(2):139-44. Scholes D et al.; Acta Obstet Gynecol Scand. 2004 Oct;83(10):909-11. Ziaei S et al.; Virology. 2006 Aug 15;352(1):169-77. Trunova N et al.; AIDS. 2004 Jan 23;18(2):205-9. Wang CC et al.; J Infect Dis. 1998 Oct;178(4):1053-9. Martin HL Jr et al.

P. 79: Dairy products have higher levels of estrogen than currently recognized: 

J Agric Food Chem. 2006 Dec 27;54(26):9785-91. Malekinejad H et al.
P. 71: Report of significant early decline in testosterone levels in men: 

J Endocrinol & Metab. 2007 Jan;92(1)44-45. Travison TG et al.
P. 84: Low levels of estrogen associated with decrease in vascular tone: 

Ob Gyn News April 15 2005. Wkdman RP. Swan study
P. 84: Low levels of estrogen associated with increase in arterial sclerosis: 

Fertil Steril. 2004:82:391-7. Mack WY et al.
P. 84: Low levels of estrogen associated with increase incidence of heart attack and stroke: 

Ann NY Acad Sci. 1990;592:193-203. Stampfer MJ et al.
P. 84: Estrogen replacement associated with decrease of 60% in aortal calcification: 

NEJM 2007 Jun;356:259-602. Manson JA et al.
P. 84: Reasons women should be focused on maintaining natural estrogen levels: 

Am J Obstet Gynecol. 1967;99:155-62. Parrish H et al.
P. 84: Estradiol prevents thickening of heart walls: 

Br Med J. 1989;298:642-4. Witterman J et al.
P. 84: Estradiol prevents heart failure: 

Basic Res Cardiol. 2006 Jul 4; Beer S et al.
P. 84: Estradiol prevents thickening of heart walls: 

Nucl Recept Signal. 2006;4:e013. Kim JK et al.
P. 84: Estradiol treatment decreases fibrinogen: 

Menopause. 2006 Jul-Aug;13(4):643-50. Zegura B et al.
P. 85: Estradiol lowers homocysteine: 

Menopause. 2001 Jul-Aug:8(4):252-8. Ventura P et al.
P. 85 Estradiol decreases the thickening of the carotid artery walls: 

Hypertens Res. 2005 Jul;28(7):579-84. Sumino H et al.
P. 85: WHI study causes recommendation to stop supplementing all hormones fail to distinguish between bioidentical and chemicalized estrogens: 

JAMA. 2002;288:321-333. Women’s Health Initiative (WHI Study) et al.
P. 86: Estradiol alone in the presence of arterial sclerosis will exacerbate this condition: 

J Clin Endocrinol Metab. 2006 Dec;91(12):4995-5001. Seli E et al.
P. 86: The medical community started to understand the toxic effect of HRT and the more beneficial affect of natural HRT on the cardiovascular system: 

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):777-89. Koledova VV et al.
P. 86: Cholesterol metabolite 27 hydroxycholesterol inhibit the cardiovascular protection of estrogen: 

Nat Med. 2007 Sep 16;Umetani M et al.
P. 86: Bioidentical progesterone decreases apatosis and downregulates Fas and Fas expression: 

Biol Reprod. 2004 Dec;71(6):2065-71. Okuda K et al.; Febs Lett. 2000 Jan 28;466(2-3):279-82. Kuranaga E et al.
P. 86: Bioidentical estradiol applied to skin increases adiponectin: 

Fertil Steril. 2006 Dec;86(6)1669. Chu MC.
P. 86: Ghrelin causes cravings and increases hunger: 

Physiol Behav. 2006 Aug 30;89(1):71-84. Cummings DE.
P. 87: Bioidentical estradiol applied to skin decreases ghrelin: 

Fertil Steril. 2006
Dec;86(6)1669. Micheline CC et al.
P. 87: Bioidentical estradiol increases CCK, satiety, and decreases food intake: 

Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1251-63. Asarian L et al.
P. 87 Decline of estrogen leads to binge-eating: 

Psychol Med. 2006 Oct 12;:1-11. Edler C et al.
P. 87: Prolonged estradiol treatment increases insulin sensitivity: 

Mol Endocrinol. 2006 Jun;20(6):1287-99. Gao H et al.
P. 87 Premarin increases body fat and decreases lean body mass: 

Adv Ther. 2006 Mar-Apr;23(2):263-73. Delibasi T et al.
P. 87: Bioidentical estradiol cream is more effective in managing weight and insulin sensitivity than capsule form: 

Fertil Steril. 2006 Dec;86(6)1669. Micheline CC et al.
P. 87: Estrogen behaves like an antioxidant: 

Swiss Med Wkly. 2006 Aug 5;136(31-32):510-4. Delibasi T et al.
P. 87: Estradiol decreases IL-6: Gynecol Obstet Mex. 2006 Mar;74(3): 

133-8. Saucedo Garcia R et al.; J HuazhongUniv Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 87: Estradiol decreases NF-?B: Cytokine. 2005 Aug 21;31(4):

251-7. Liu H et al.; J HuazhongUniv Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 88: Failing to maintain estrogen levels may cause permanent memory loss: 

J Neuroendocrinol. 2007 Feb;19(2):77-81. Sherwin BB.
P. 89: Estrogen decreases chronic hepatitis fibrosis via antioxidant effect: 

Braz J Infect Dis. 2007 Jun;11(3):371-4. Codes L et al.
P. 89: Scientific data on the benefits of estrogen beyond reproductive function: 

Endo Reviews. 2005 26(3):308-312. Wise PM et al.
P. 89: Estrogen improves levels of Acetylcholine: 

Brain Res. 2000;864(2):263-69. Farr SA et al.
P. 89: Estrogen improves levels of serotonin: 

Psychopharmacol Bull. 1997;33(2):229-33. Chakravortv SG et al.; Life Sci. 1998;63(3):155-60. Holschneider DP et al.; Endocrinology. 2002 Oct;143(10):3974-83. Temels S et al.
P. 89: Estrogen enhances norepinephrine function: 

Endocrinology. 2002 Oct;143(10):3974-83. Temel S et al.
P. 89: LH increase as sign of estrogen decline and associated with cognitive decline: 

Mol Cell Endocrinol. 2007 apr 15;269(1-2):107-11. Casadesus G. et al.
P. 89: Estrogen increases executive function and cognitive function: 

Horm Behav. 2006 Dec 13; Norbury R et al.
P. 89: Estrogen increases verbal memory: 

Ann N Y Acad Sci. 2005 Jun;1052:3-10. Sherwin BB.
P. 89: Estrogen increases cognitive recognition: 

Women Health. 2006;43(1):37-57. Stephens C et al..
P. 89: Estrogen increases spatial memory: 

Neurobiol Aging. 2006 Apr 16; Harburger LL et al.; Women Health. 2006;43(1):37-57. Stephens C. et al.
P. 89: Estrogen increases BDNF: 

Front Neuroendocrinol. 2006 Oct 19; Scharfman HE et al.
P. 90: Estrogen prevents brain grey matter loss: 

Menopause. 2006 Jul-Aug;13(4):584-91. Boccardi M et al.
P. 90: Estrogen prevents brain white matter loss: 

Neurobiol Aging. 2006 Oct 6; Ha DM et al.
P. 90: Estrogen protects against Alzheimer’s Disease: 

Adv Etp Meg Bio. 1997;429:261-71. Chang D et al.; Menopause. 2006 Jul-Aug;13(4):584-91. Boccardi M et al.
P. 90: Estrogen protects against injury from stroke: 

Trends Neurosci. 2001 Jul;24(7):386-91. Stein DG.
P. 90: Estrogen protects against injury from epilepsy: 

Neuroscientist. 2007 Feb;13(1):77-88. Veliskova J.
P. 90: Estrogen protects against stress-induced damage to hippocampal calls: 

Neuroscience. 2007 Feb 21; Takuma K et al.
P. 90: Low levels of estrogen in beginning of woman’s cycle are associated with depression: 

Arch Gen Psychiatry. 2000 Dec;57(12):1157-62. Young EA et al.
P. 90: Women in peri-meopause experience greater incidence of depression: 

North American Menopause Society 2007. Schmidt PJ et al.
P. 90: Depressed women enter menopause earlier: 

Arch Gen Psychiatry. 2001 June;58(6):529-34. Soares CN et al.
P. 90: Estrogen improves mood, decrease post partum depression and anxiety: 

Psychoneuroendocrinology. 2007 May;32(4):350-7. Hill MN et al
P. 91: Postpartum depression and psychosis successfully treated with estrogen: 

J Clin Psychiatry. 2000 Mar;61(3):166-9. Ahokcas A et al.
P. 91: Non-responsive depression successfully treated with estradiol: 

Arch Gen Psychiatry.. 1997 May;36(5):550-4. Klaiber EL et al.
P. 91: Depressed peri-menopausal women who do not respond to SSRI after administration of estrogen improve their mood: 

J Clin Psychiatry. 2002;63 Suppl 7:45-8. Rasgon NL et al.
P. 91: Estrogen acts as an MOA Inhibitor: 

Psychopharmacol Bull. 1997;33(2):229-33. Chakravortv SG et al.; Life Sci. 1998;63(3):155-60. Holschneider DP et al.
P. 91: Estrogen improves production of Serotonin and Norepinephrine: 

Brain Res. 2000;864(2):263-69. Farr SA et al.
P. 92: Bioidentical estrogen has a significant positive effect on panic attacks: 

Orv Hetil. 2006 May 14;147(19):879-85. Magyar Z et al.; J Affect Disord. 2001 Oct;66(2-3):273-9. McManus K et al.; J Clin Psychiatry. 1995 Nov;56(11):533. Chung CK et al.
P. 94: Migraines are more frequent on days estrogen levels decline: 

Headache. 2006 Oct;46 Suppl 2:S49-54. Zacur HA.
P. 94: Migraines less frequent on days estrogen levels rise: 

Neurology. 2006 Sep 13: Macgregor EA et al.; Neurology. 1991 Jun;41(6):786-93. Silberstein SD et al.
P. 94: Migraines less common in pregnancy: CNS Drugs. 2006;20(2):

125-41. Ashkenazi A et al.
P. 94: Migraines are more frequent when estrogen levels drop: 

Headache. 1978;17:250. Ryan et al.
P. 94: Migraines more frequent immediately after delivery: 

Neurology. 1972;22:355. Somerville et al.; CNS Drugs. 2006;20(2):125-41. Ashkenazi A et al.
P. 94: Relationship between migraines and changing levels of estrogen: 

Neurology. 2006 Sep 13: Macgregor EA et al.
P. 94: "Menstrual migraines are due to low level of estrogen": 

Neurology. 1991 Jun;41(6):786-93. Silberstein SD et al.; The Female Patient. 2006 Sept;31 12-20. Rozen T.
P. 95: Bioidentical estrogen causes brighter appearance, rounder, fuller, rosier lips: 

Proc Biol Sci. 2006 Jan 22;273(1583):135-40. Smith MJ et al.
95: Bioidentical estradiol and estriol cream increases elasticity firmness, decreases wrinkle depth and pore size of the skin: 

Int J Dermatol. 1996 Sep;35(9):669-74. Schmidt JB et al.; Climacteric. 2007 Aug;10(4):289-97. Verdier-Sevrain S.
P. 95: Estrogen treatment improves visual function: 

Meno. 2003;10(1)53. Guaschimo S et al.
P. 95: Estrogen treatment prevents intraocular pressure and improves amount/quality of eye lubrication: 

Ophthalmologica. 2004 Mar-Apr;218(2):120-9. Altintas O et al.
P. 95: Premarin is associated with higher incidents of Dry Eye Syndrome:
Gynecol Endocrinol. 2006 Sep;22(9):501-5. Uncu G et al
P. 95: Estrogen deficiency is associated with age-related hearing loss: 

Amer J. Ob/Gyn.2004 Jan;190(1):77-82. Kilicdag EB et al.
P. 95: Estrogen help muscle development and healing rates: 

J Appl Physiol. 2006 Jun;100(6):2012-23. McClung JM et al.
P. 95: Estrogen decreases incidents of duodenal stress ulcers: 

Am J Physiol Gastrointest Liver Physiol. 2006 Oct5; Shimozawa N et al.
P. 96: Estrogen decrease gastric cancer due to H Pylori bacteria: 

Carcinogenesis. 2007 Aug 27; Ohtani M et al.
P. 96: Estrogen promotes energy; particularly in women with CFS: 

J Clin Pathol. 2006 May 26; Grans H et al et al.
P. 97: Protective effects of estriol established more than 35 years ago: 

Ann Intern Med. 1978 Sep;89(3):422-3. Lemon HM.
P. 97: Estriol restores vaginal integrity: JAMA. 1978 Apr 21;239(16):

1638-41. Tzingounis VA et al.; J Med Assoc Thai. 2001 Apr;84(4):539-44. Manonai J et al.
P. 97: Estriol does not promote uterine tissue growth which may decrease the incidence of uterine cancer: 

Comp Biochem Physiol C. 1990;96(2):241-4. Tamaya T et al.; JAMA. 1978 Apr 21;239(16):1638-41. Tzingounis VA et al.
P. 97: Estriol quickly alleviates night sweats and hot flashes: 

JAMA. 1978 Apr 21;239(16):1638-41. Tzingounis VA et al.; Zhonghua Yi Xue Za Zhi (Taipei). 1995 May;55(5):386-91. Yang TS et al.; Maturitas. 2000 Feb 15;34(2):169-77. Takahashi K et al.
P. 97: Estriol has decreases NFkB: J Neuroimmunol. 2002 Mar;124(1-2):

106-14. Zang YC et al.
P. 97: Estriol reduce coronay hyperactivity: 

Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H295-303. Mishra RG et. al
P. 97: Estriol decreases TNF-a: J Immunol. 2003 Dec 1;171(11):

6267-74. Soldan SS et al.
P. 97: Estriol may help build bone: 

Gynecol Endocrinol. 2003 Dec;17(6):455-61. Yamanaka Y et al
P. 97 UCLA study of bioidentical estriol in the treatment of MS: 

Neurology. 1999 Apr 12;52(6):1230-8. Kim S et al.; J Immunol. 2003 Dec 1;171(11):6267-74. Soldan SS et al.; Ann Neurol. 2002 Oct;52(4):421-8. Sicotte NL et al.
P. 98: Estrogen beta receptor deficiency may cause interstitial cystitis: 

Proc Natl Acad Sci USA. 2007 Jun 5;104(23):9806-9. Imamov O et al.; J Endocrinol. 2007 June;193(3):421-33. Treeck O et al.
P. 98: Estriol affects beta receptors that decrease breast tissue proliferation: 

Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Endocrinology. 2007;148(2):538-547. Cvoro A et al.
P. 98: Estriol prevents breast cancer cells from producing new blood vessels and VEGF: 

Cancer Res. 2006 Dec 1;66(23):11207-13. Hartman J et al.
P. 98: Estriol has anti tumor effect on ovarian cancer cell: 

J Endo Crinol. 2007 Jun;193(3):421-33. Treeck O et al.
P. 105: Estridol patch delivers unpredictable amounts of estrogen: 

Fertil Steril. 2003 Mar;79(3):534-42. Kraemer GR et al.
P. 107: Low-dose Estradiol patch provides too little to benefit cognitive function: 

Arch Neurol. 2006 Jul;63(7):945-50. Yaffe K et al.
P. 107: Intermittent dosing of estrogen impairs cognition: 

Brain Res. 2006 Oct 18;1115(1):135-47. Gresack JE et al.
P. 108: Studies indicate birth control pills cause decline in cognition: 

J Nerv Ment Dis. 1999 May;187(5):275-80. Rubino-Watkins MF et al.

P. 112: Balancing effect of estrogen by progesterone important for preventing development of cancer: 

J Clinc Endo Metab. 2002;87(1):3-15. Hale et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14021-6. Pan H et al.
P. 112: Progesterone blocks UroKinase Pasminogen Activator and protect breat cancer proliferation: 

J Steroid Biochem Mol Biol. 2001 Aug;78(2):185. McDonnel et al.; Clin Cancer Res. 2001 Sep;7(9):2880. Lin V et al.
P. 113: Progesterone blocks NF-KBeta and Cox-2 and protect breast cancer: 

J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR et al.
P. 113: Progesterone protects breast tissue from HER 2/new oncogene: 

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):241-9. Mendelson CR et al.
P. 113: Study showing that cancer biomarkers increased in primate group taking Provera while not in group taking progesterone: 

Breast Cancer Res Treat. 2007 Jan;101(2):125-34. Wood CE et al.
P. 113: Women who are operated on to remove breast cancer during cycles when progesterone present enjoy increased survival rate: 

Breast J. 2006 Nov;12(6):518-525. Kontos M et al.
P. 113: Use of bioidentical progesterone cream on breasts to decrease benign and overall incidence of breast cancer: 

Cancer Detect Prev. 1999;23:290-298. Plu-Bureau G et al.
P. 114: Johns Hopkins study of significant increase mortality, cancer, and breast cancer in women who had low progesterone vs. normal progesterone: 

Am J Epidemiol. 1981;114(2):209-17 Cowan LD et al.
P. 114: French study showing increase in breast cancer for women using chemical progesterone and decrease for those who used bioidentical progesterone: 

Int J Cancer. 2005 Apr10;114(3):448-54. Fournier A et al.
P. 114: Study showing women who used no hormones (vs. those using bioidentical progesterone and estrogen) increase in breast cancer: 

Gynecol Endocrinol. 2006 Aug;22(8):423-431 Espie M et al.
P. 115: Progesterone inhibits VCAM-1: 

Arterio Thromb Vas Biol. 2001;21:243-8. Otsuki M et al.

P. 115: Progesterone promotes the function and maintenance of brain: 

J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.
P. 115: Progesterone increases myelin: 

J Neurotrauma. 2006 Feb;23(2):181-92. Labombarda F et al.
P. 115: Progesterone significantly aids in decreasing brain edema: 

Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al 

P. 115: Progesterone increases production of GABA: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D.; Brain Res. 1995 May 22;680(1-2):135-41. Picazo O et al.; Psychopharmacology (Berl). 2006 Jun;186(3):312-22. Frye CA et al.: J. Women’s health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.
P. 115: Progesteron increase BDNF and decrease glutamate toxicity: 

J Neurosci Res. 2007 Aug 15;85(11):2441-9. Kaur P et al.
P. 116: Women given Provera for five years and switched to bioidentical progesterone for 6 months improve mood, decreased anxiety and depression: 

J Women’s Health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.
P. 116: Progesterone helps you to fall a sleep and maintain your sleep: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Menopause. 2001;8(1):10-16. Montplaisir J et al.; Curr Med Chem. 2006;13(29):3575-82. Andersen ML et al.
P. 116: Progesterone improves immunity: 

J Cell Biochem. 2006 Sep 1;99(1):292-304. Chien EJ et al.
P. 116: Progesterone builds bones: 

Zhonghua Fu chan Ke Za Zhi. 1997 Sep;32(9):538-40. Chen L et al.; Zhonghua Fu chan Ke Za Zhi. 2004 Apr;39(4):250-3. Liang M et al
P. 117: Progesterone improves hearing: 

Neuropsychologia. 2002;40(8):1293-9. Alexander GM et al. 

P. 117: Progesterone protects from seizures: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D et al.; Brain Res. 1995 May 22;680(1-2):135-41. Picaso O et al.; Brain Res. 2006 Jul 26;1101(1):110-6. Lonsdale D et al.; Neurosci Lett. 2007 Jan 10;411(2):147-51. Lonsdale D et al.
P. 117: Progesterone decreases allergies: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone decreases IBS: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone decreases Interstitial Cystitis: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone prevents and resolves water retention: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al.
P. 117: Progesterone a strong antagonist of Aldosterone: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al
P. 117: Progesterone decrease cocain craving: 

Exp Clin Psychopharmacol. 2007 Oct;15(5):472-80. Anker JJ et al.
P. 123: Studies show women with PMS have low levels of progesterone and allopregnenolone: 

Obstet Gynecol. 1997 Nov:90(5):709-14. Rapkin AJ et al.; Eur J Endocrinol. 2000 Mar;142(3):269-73. Monteleone P et al.
P. 123: Article showing benefit of supplementing bioidentical estrogen in PMS: 

Br J Obstet Gynaecol. 1995 Jun;102(6):475-84. Smith RN et al.
P. 123: Decreased levels of estrogen causation of PMS: 

J Br Menopause Soc. 2004 Dec;10(4):151-6. Hassan I et al.; Psychol Med. 2006 Jul;36(7):901-12. Saunders KE et al.
P. 125: Supplementing absorbable Magnesium benefits women with PMS: 

Obstet Gynecol. 1991 Aug;78(2):177-81. Facchinetti F et al.; Clin Drug Investig. 2007;27(1):51-8. Quaranta S et al.
P. 125: Magnesium Oxide does not resolve PMS: 

J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. De Souza MC et al.
P. 125: Vitamin B6 shown to provide moderate benefits in PMS: 

J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. De Souza MC et al.; J R Coll gen Pract. 1989 Sep;39(326):364-8. Doll H et al.
P. 126: Studies indicate physical activity can relieve many discomforts of PMS: 

Women Health. 2004;39(3):35-44. Lustyk MK et al.
P. 126: Vaginal Progesterone cream thins the uterine lining and decreases fertility: 

Fertil Steril. 1999 Nov;72(5):830-6. Dumario MA et al.
P. 126: Endometriosis occurs when an increase of oxidative stress and the presence of free radicals: 

Hum Reprod. 2005 Jul;20(7):2014-20. Jackson LW et al.; J Soc Gynecol Investig. 2006 Sep;13(6):390-8. Alpay Z et al.
P. 126: Endometriosis occurs with an increase of aromatization: 

Endocr Relat Cancer. 1999 Jun;6(2):293-301. Bulun SE et al.; Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):144-50. Ebert AD et al.; Semin Reprod Med. 2004 Feb;22(1):45-50. Bulun SE et al.; Hum Reprod Updae. 2006 Jan-Feb;12(1):49-56. Attar E et al.; Fertil and Steril. 1999 Dec;72(6):961-1106. Khaled M et al.
P. 126: Endometriosis occurs with an increase in inflammation: 

Fertil Steril. 2005 May;83(5):1530-5. Horie S et al.; Fértil Steril. 2004 Oct;82 Suppl 3:1023-8. Yamauchi N et al.; Fertil Steril. 2005 Mar;83(3):529-37. Osteen KG et al.; Am J Reprod Immunol. 2006 Oct;56(4):267-74. Kitawaki J et al.
P. 126: Endometriosis occurs with a compromised immune system: 

Biol Reprod 2005 Sep;73(3):565-70. Cao WG et al.; Fertil and Steil. 2006;86(5):1336- Anaf V et al.
P. 126: Relieving stress will decrease inflammation: 

Neurol Clin. 2006 Aug;24(3):483-91. Avitsur R et al.
P. 126: Relieving depression decrease inflammation: 

Arch Intern Med. 2007 Jan 22;167(2):174-81. Ranjit N et al.; Psychosom Med. 2006 Jul-Aug;68(4):538-46. Taylor CB et al.
P. 126: Physical activity will restore body’s control over inflammation: 

J Physiol Pharmacol. 2006 Nov;57 Suppl 10:43-51. Petersen AM et al.; Essays Biochem. 2006;42:105-17. Pedersen BK et al.
P. 126: Bioidentical progesterone resolves root causes of Endometriosis: 

J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14021-6. Pan H et al.; Fertil and Steil. 2006;86(5):1336- Anaf V et al.; Fertil Steril. 2005 May;83(5):1530-5. Horie S et al.; Fertil Steril. 2004 Oct;82(3):1023-8. Yamauchi N et at.
P. 128: Depo-Provera causes weight gain: 

Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.
P. 128: Depo-Provera increases incidence of bladder infections: 

Acta Obstet Gynecol Scand. 2004 Oct;83(10):909-11. Ziaei S et al.
P. 128: Depo-Provera increases incidence of diabetes: 

Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.
P. 128: Depo-Provera increases risk of Chlamydia and Gonorrhea infection: 

Sex Transm Dis. 2004 Sep;31(9):561-7. Morrison CS et al.
P. 128: Depo-Provera increases rate of acquisition of HIV infection: 

J Infect Dis. 1998 Oct;178(4):1053-9. Martin HL Jr et al.
P. 128: Depo-Provera increases ability to infect others with HIV: 

AIDS. 2004 Jan 23;18(2):205-9. Wang CC et al.
P. 128: Depo provera increases milk production in not pregnant users: 

Scientific World Journal. 2006 May 5;6:538-41. Omar HA et al.

P. 138: HGH treatment decreases cholesterol, triglycerides, and fibrinogen levels: 

Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.; Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7. Nam SY et al.
P. 132: HGH prevents and slows progression of arterial schlerosis: 

J Clin Endo Metab. 2005 Apr;90(4):2056-62. Colao A et al.; J Clin Endo Metab. 2005 May;90(7):3978-82. Lanes R et al.
P. 132: HGH improves condition of women with chronic heart failure: 

J Clin Endocrinol Metab. 2006 Oct 24; Lecorvosier P et al.; Horm Metab Res. 2006 Oct;38(10):656-61. Wallaschofski H et al.
P. 132: HGH improves bone density by increasing amylin levels: 

J Of Cell Biology. 2004 Feb;164(4):509-14. Dacquin R et al.
P. 132: HGH treatment improves bone density in hips: 

J Endocrinol Invest. 2005;28(8SUPPL):32-6. Agnusdei D et al.; Curr Pharm Des. 2002;8(23):2023-32. Svensson J.
P. 133: HGH treatment improves growth of bone in spine: 

Curr Pharm Des. 2002;8(23):2023-32. Svensson J.
P. 133: HGH burns omental, trunk and visceral fat that surrounds internal organs: 

Growth Horm IGF Res. 2006 Nov 20; Albert SG et al.; Horm Metab Res. 2005 Jan;37(1):49-52. Herrmann BL et al.; Curr Med Res Opin. 2006 Oct;22(10):1973-9. Chihara K et al.; Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.; Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7. Nam SY et al.
P. 133: Children with low levels of HGH also have low adiponectin: 

J Pediatr. 2006 Sep;149(3):324-9. Lanes R et al.
P. 134: HGH improves capacity to exercise: 

Am J Cardiol. 2006 Apr 1;97(7):1097-102. Climent VE et al.
P. 134: Natural HGH rises when young adults exercise: 

Horm Res. 2006;56(2):57-61. Stokes K.
P. 134: When young adults exercise in the cold weather HGH levels does not increase: 

Growth Horm IGF Res. 2006 Apr;16(2):125-31. Wheldon A et al.
P. 134 When older adult exercise they do not increase their HGH levels: 

Horm Res. 2006;65(2):57-61. Stokes K et al.
P. 134: Women with low HGH levels do not sleep well: 

Neuroendocrinology. 1990 Jan;51(1):82-4. Astrom C et al.
P. 134: HGH treatment helps women to sleep: 

Clin Endocrinology. (Oxf) 1990 Oct;33(4):495-500. Astrom C et al.
P. 134: If women with severe HGH deficiencies are taken off HGH they experience psychological deterioration. 

Clin Endocrinol. (Oxf) 2003 Oct;59(4):467-75. McMillan CV et al.
P. 135: HGH has positive affect on brain fuction: 

Endocrin Reviews. 2005 Dec;26(7):916-943. Russo V.C et al.
P: 135: HGH improves quality of life: 

J. Clin Endocrinol Metab 2006 May;91(5):1621-34. Molitch ME et al.
P. 135: Higher levels of HGH associated with faster and more effective recovery from stroke: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3928-34. Bondanelli M et al.
P. 135: Supplementation of HGH does not decrease body’s production of HGH: 

J Clin Endo Crinol Metab. 1990 Jun;70(6):1612-5. Wu RH et al.
P. 135: HGH improves ovarian function: 

Eur J Endocrinol. 1996 Feb;134(2):190-6. Bergh C et al.
P. 136: HGH promotes fertility by participating in ovarian follicle development: 

Fertil S:teril. 1996 Dec;66(6):948-53. Lanzone A et al.
P. 136: HGH improves response to Clomid: 

Fertil Steril. 2000 Jan;73(1):78-84. Rossato P et al.
P. 136: HGH improves response to in vitro fertilization: 

Med Hypotheses.1997 Nov;49(5):413-5. Orvieto R et al.; Gynecol Endocrinol. 1991 Mar;5(1):33-6. Homburg R et al.
P. 136: HGH improves every aspect of reproduction: 

Clini Endo Meta. 1990 Jun;70(6):1612-5. Wu RH et al.
P. 136: HGH improves energy in women with Fibromyalgia: 

Am J Med. 1998;104(3):227-31. Bennett RM et al.
P. 136: HGH should always be considered for anemic women: 

J Endocrinol Inves. 2006 May;29(5):399-404. Bergamaschi S et al.
P. 136: HGH has significant benefit with every aspect of skin function: 

J Orthop Res. 2002 Sep;20(5):910-919. Dahlgren LA et al.
P. 137: Burn victims have a lower mortality rate when treated with HGH: 

Zhonghua Shao Shang Za Zhi 2005 Oct;21(5):347-9. Chen GX et al.
P. 140: HGH shown to support and reinforce the immune system: 

J Clin Endocrin Metab.1997 Nov;82(11):3590-6. Khorram O et al.
P. 140: HGH increases monocyst: J Clin Endocrin Metab.1999 Jan;84(1):58-63. Serri O et al.
P. 140: HGH increases Glutathion, decreases NF-Kappa Beta and help cell survival: 

Br J Cancer. 2003 Sep15;89(6):1108-15. Cherbonnier C et al.
P. 141: HGH increases Natural Killer cells: 

Metabolism. 1990 Dec;39(12):1320-4. Crist DM et al.
P. 141: Mice with stomach cancer treated with HGH has reduction in cancer progress: 

World J Gastroenterol. 2006 Jun 28;12(24):3810-3. Liang DM et al.
P. 141 HGH increases IGBP3 and IGBP3 decreases the incidence of breast cancer: 

Biochem Biophys Res Commen. 1994 Jan 14;198(1):292-7. Pratt SE et al.; J Clin Endocrin Metab 2002;87(12):5722-29. Zeleznik AJ et al.
P. 141: HGH increases EPO secretion: 

Eur J Encocrinol. 1998 Mar;138(3):302-6. Sohmiya M et al.
P. 141: HGH builds cancer-fighting white cells: 

Eur j Endocrinol. 2005 Feb;152(2):211-5. Sohmiya M et al.
P: 141: HGH builds lymphocytes: 

Endo Rev. 1997 Apr;18(2):157-179. Clark R et al.
P. 141: HGH increases adiponectin which protects the body from breast cancer: 

J Clin Endocrinol Metab. 2003 Nov;88(11):5193-8. Eden Engstrom B et al.
P. 141: Adiponectin prevents development of new blood vessels by cancer cells: 

Proc Natl Acad Sci USA. 2004;101(8):2476-81. Brakenhelm E et al.
P. 141: HGH reverses bone marrow deterioration: 

Endocrinology. 2002 Feb;143(2):690-699. French R.A et al.
P: 141: HGH does not promote cancer in adult or children: 

J Clinic Endocrinol Metab. 2001;86(5)1868-70 Consensus Statement HGH Research Society.; Clin Endocrinol (Oxf). 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: Children with brain tumors subsequently treated with HGH show no increase in formation of new tumors: Clin Endocrinol. (OXF) 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: Acromegalic adults are not representative of healthy adults who supplement HGH: 

Clin Endocrinol. (OXF) 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: HGH can decrease apatosis in patients with colon cancer: 

Endocrinolgy. 2004 Jul;145(7):3353-62. Bogazzi F et al.
P. 141: In other cancer cells HGH increases apatosis by increasing Glutathione and may be cancer protective: 

Br J Cancer. 2003 Sep15;89(6):1108-15. Cherbonnier C et al.
P. 141: "… extensive data to date… indicates that… growth hormone is safe.": 

J Clinic Endocrinol Metab. 2001;86(5):1868-70. Consensus Statement Hgh Research Society.
P. 142: HGH may improve chemotherapy response: 

Cancer Gene Therapy. 2002 Jun;9(6):497-504. Cherbonnier C et al.
P. 142: HGH improves gastric cancer treatment: 

World J Gastroenterol. 2004 Apr 15;10(8):1132-6. Chen JY et al.; World J Gastroenterol. 2006 Jun 28;12(24):3810-3. Liang DM et al.
P. 142: HGH counteracts bone marrow suppression during chemotherapy: 

Blood. 1992 Sep 15;80(6):1443-7. Murphy WJ et al.; Endocr Rev. 1997 Apr;18(2):157-79. Clark R.; Endocrinology. 2002 feb;143(2):690-9. French RA et al.
P. 142: HGh treatment administered to diabetic obese patients improve insulin sensitivity: 

Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.
P. 142: HGH increases amylin that protects from diabetes: 

Scientific World Journal. 2006 DEC 15;6:1642-55. Wookey PJ.; Eur J.Endocrinol. 2000 Nov;143(5):593-9. Jorgensen JO et al.
P. 142: HGH increases adiponectin that protects from diabetes: 

Horm Metab Res. 2005 Jan;37(1):49-52. Herrmann BL et al.
P. 142: HGH reduces overall body fat: 

Clin Endocrinol. (Oxf) 2003 Oct;59(4):467-75. McMillan CV et al

P. 144: By ages 50-60 most will lose 70% of DHEAS level enjoyed in 20s: 

Endo Reviews. 2003 Apr;24(2):152-182 Labrie F et al.; J Clin Endo Met. 1992;75(4):1002-4 Orentreich N et al.; J Clin Endocrinol Metab. 1984;59(3):551-5. Orentreich N et al.
P. 144: DHEA levels peak between ages 20-30/plummet between ages 50-60: 

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.; J Clin Endo Met. 1992;75(4): 1002-4 Orentreich N. et al.
P. 144: DHEA levels decline less after age 60: 

J Clin Endo & Metab. 1997 ;82: 2396-2402 Lebrie F et al.
P. 144: Measurable decline in DHEA production after hysterectomy: 

Fertil Steril. 2006 Oct;86(4): 981-9 Hassa H et al.
P. 146: Promising reports of DHEA: 

Fertil Steril. 2003 Dec;80(6): 1495-501 Genazzani AD et al.; J Clin Endocrinol Metab. 1999;84(9)3260-7 Solerte SB et al.; Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.; Cell Mol Immunol. 2006 Feb;3(1): 41-5 Wang YD et al.; J Clinic Endo and Metab. 2002 May;87(5): 2046-52 Gudmundur J et al.
P. 146: Negative DHEA reports: 

N Engl J Med. 2006 Oct 19;355(16): 1647-59 Nair KS et al.; Semin Reprod Med. 2006 Apr;24(2): 97-105 Saltzman E et al.; Treat Endocrinol. 2005;4(2): 95-114 Cameron DR et al.; Trends Endocrinol Metab. 2002 Sep;13(7): 288-94 Allolio B et al.
P. 146: DHEAS—ready to use when needed: 

Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 147: Androgens play important role in women’s health: 

Gynecol Endocrinol. 2006 Mar;22(3): 118-30 Labrie F.
P. 147: Supplementing DHEA decreases breast cancer: 

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.; World J Surgery. 2007 Apr 4; Published Online Hardin C et al.
P. 147: DHEA suppressed growth of human breast cancer cells in mice: 

Carcinogenesis 2003;105(3):321-325. Ciolino H et al.; Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et at.; Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
P. 147: DHEA inhibits progression of breast cancer: 

Cáncer J. 2006 Mar-Apr;12(2): 160-5 Gayosso V et al.; Breast Cancer Res. 2005;7(6) R1132-40 Shilkaitis A et al.
P. 147: Aromatase inhibitors (regular breast cancer treatment) in the absence of androgens are not as efficient as could be: 

Endocrin-Related Cancer. 2006 Aug 1;13: 335-355 Labrie F.; Cancer Res. 2006 Aug 1;66(15): 7775-7782 Macedo LF et al.
P. 147: DHEA suppresses production of 4 Hydroxy esterone (that may increase breast cancer): 

CG. Mol Cell Biochem. 1999;198: 89-100. Ikegwuonu FI et al.; Carcinogenesis 2003;105(3):321-325 Ciolino H et al.
P. 148: Multiple studies show general anti-cancer effect of DHEA: 

Cancer Lett. 1997 Jun 3;116(1): 61-69 Wang TT et al.; Carcinogenesis 2003;105(3):321-325. Ciolino H et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on pancreatic cancer: 

Surgery. 1997;121(4): 392-7 Melvin WS et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on colon cancer: 

Carcinogenesis. 1984;5(1): 57-62 Nyce JW et al.; Cancer Res. 1992;52:1372-76. Schulz S et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on prostate cancer: 

Cancer Res. 1999 Jul 1;59(13): 3084-9 Rao KV et al.
P. 148: DHEA benefits the cardiovascular system: 

J Cardiovasc Pharmacol. 2005 Sep;46(3): 325-32 Hutchison SJ et al.; Endocrinol Pol. 2005 Nov-Dec;56(6): 904-10 Rabijewski M et al.; Circulation. 1993;87: 261-9 Eich DM et al.
P. 148: Low DHEA associated with increase atherosclerosis: 

Euro J Endocrinol. 2007 Jun;156(6):687-93
P. 148: DHEA inhibits platelet aggregation: 

Ann NY Acad Sci. 1995;774: 281-90 Jesse RL et al.
P. 148: DHEA reverse aging process of left heart ventricle: 

Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1): R251-6 Alwardt CM et al.
P. 148: DHEA protects the cardio vascular system: 

J Nut Cancer Inst. 1998 may 20;90(10):772-80. Couillard S et al.
P. 148: DHEA is high in Polycistic Ovarian Syndrome patients as cardio protective reponse by their bodies: 

Eur J Endocrinol. 2006 Jun;154(6): 883-90 Dagre A et al.
P. 149: DHEA improves overall condition of diabetes: 

Ann NY Acad Sci. 1995;774: 291-3 Bates GW et al.
P. 149: DHEA improves insulin sensitivity: 

Euro J Endo. 2001 Oct;145(4): 457-61 Lasco A et al.
P. 149: DHEA increases pancreatic cells: 

FEBS Lett. 2006 Jan 9;580(1): 285-90 Medina MC et al.
P. 149: EA decreases insulin resistance in people with coronary disease: 

Endokrynol Pol. 2005 Nov-Dec;56(6): 904-10 Rabijewski M et al.
P. 149: DHEA protects diabetic patients from oxidative stress: 

Diabetes Care. 2007 Aug 17; Brignardello E et al.
P. 149: DHEA increases adiponectin: 

Endocrinology Reviews. 2005;26(3): 439-451 Kadowaki T et al.
P. 149: Supplementing DHEA up-regulates adiponectin levels: 

Eur J Endocrinol. 2006 Oct;155(4): 593-600 Hernandez-Morante JJ et al.
P. 149: DHEA increases NK activity: 

J Clin Endocrinol Metab. 1999;84(9)3260-7 Solerte SB et al.
P. 149 DHEA slows onset of autoimmune disease: 

Autoimmunity. 1997;26(3): 161-71 Norton SD et al.
P. 150 DHEA improves wound healing: :

J Invest Dermatol. 2005 Nov;125(5): 1053-62 Mills SJ et al.
P. 150: DHEA Enhances body’s response to viral disease: 

J Gen Virol. 2005 Sep;86(9): 2513-23 Chang CC et al.
P. 150: DHEA enhances body’s response to parasite and bacteria: 

Crit Care Med. 2001;29(2): 380-4 Berbeck R et al.
P. 150: DHEA reduces body’s inflammation response: 

J Interferon Cytokine Res. 2006 Jan;26(1): 34-9 Powell JM et al.
P. 150: DHEA decreases pro-inflammatory cytokines: 

Atherosclerosis. 2006 Mar 28; Gutierrez G et al.; J Clin Endo Metab. 2004 Jul;89(7): 3449-54 Iwasaki Y et al.
P. 150: DHEA decreases incidence of cold, flu, and allergies: 

Vaccine. 1995;13(15)L1445-8. Danenberg HD et al.; J Am Geriatr Soc. 1997 Jun;45(6):747-51. Degelau J et al.; J Microbiol Immunol Infect. 2002 Sep;35(3):199-202. Yu CK et al.; J Rheumatol. 2001 Jun:28(6):1259-65. Valtysdottir ST et al.
P. 150: DHEA reduces colitis: 

Endocrinology. 1997 Aug;138(8):3387-94 Luo S et al.
P. 150: DHEA reduces endometriosis: 

Atherosclerosis. 2006 Mar 28; Gutierrez G et al.
P. 150: DHEA reduces lupus: Curr Opin Invstig Drugs. 2001 Aug;2(8): 

1045-53 Dequet CR et al.; Autoimmunity. 2005 Nov;38(7): 531-40 Nordmark G et al.
P. 150: DHEA reduces psoriasis: 

Clin Exp Rheumatol. 1995 May-Jun;13(3): 345-8 De La Torre B et al.
P. 150: DHEA reduces rheumatoid arthritis: 

Arthritis Rheum. 2005 Jun;52(6): 1721-9 Weidler C et al.; J Rheumatol. 2000;59 Suppl 2: II/108-18 Straub RH et al.; J Rheumatol. 2002 Aug;29(8): 1803-5 Josipovic B et al.
P. 150: DHEA reduces osteoarthritis and joint pain: 

Rheumatol Int. 2006 Oct 11; Wu LD et al.
P. 150: DHEA functions as general anti-oxidant: 

Endocrinology. 1997 Aug;138(8): 3387-94 Luo S et al.; Cancer Res. 2001 Oct 15;61(21)7449-55. Green J et al.; Brain Res Mol Brain Res. 1999;66(1-2):35-41. Bastianetto S et al.
P. 150: DHEA decreases depression and improve felling of well-being: 

J Clin Endocrinol Metab. 2006 Oct ;91(10): 3773-9 Brooke AM et al.; Am J Psychiatry. 2006 Jan;163(1): 59-66 Rabkin JG et al.; J Clinic Endo and Metab. 2002 May;87(5): 2046-52 Gudmundur J et al.; Amer J Psychiatry. 1999 Apr;156(4): 646-9 Woldowitz OM et al.; Autoimmunity. 2005 Nov;38(7): 531-40 Nordmark G et al.
P. 150: DHEA treatment may resolve depression in children: 

Eur Neuropsychopharmacol. 2007 Aug 20; Malkesman O et al.
P. 150: DHEA shown to reduce anxiety: 

Pharmacol Biochem Behav. 1994 Mar;47(3): 437-41 Melchior CL et al.
P. 151: DHEA decreases cortisol: Acta Psychiatr Scand. 2006 Sep;114(3): 187-93 Yehuda R et al.; J Clin Endocrinol Metab. 1996 Nov;81(11): 3951-60 Guazzo EP et al.
P. 151: DHEA increases estrogen: Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 151: DHEA increases progesterone and allopregnenolone: 

Maturitas. 2003 Jul 25;45(3): 231-5 Nadjafi-Triebsch C et al.
P. 151: DHEA decrease pain: 

FASEB J. 2007 Aug 24; Kibaly C et al
P. 151: DHEA protects the hippocampus from injury and free-radicals: 

J Neurochem. 2002 Nov;83(3): 713-26 Steckelbroeck S et al.; Neuropharmacology. 2006 Oct;51(5): 958-66 Li Z et al.; Brain Res Mol Brain Res. 1999;66(1-2): 35-41 Bastianetto S et al.
P. 151: DHEA an effective treatment in vascular and neuronal-related disease: 

Amer J Physiol Endocrinology and Metabolism. 2002 Nov;283(5): E1067-75 Yorek MA et al.
P. 151: DHEA improves muscle mass and strength following resistance exercises: 

Am J Physiol Endocrinol Metab. 2006 Nov;291(5): E1003-8 Villareal DT et al.
P. 151: DHEA improves bone mass: 

Cell Mol Immunol. 2006 Feb;3(1):41-5. Wang YD et al.; Clin Endocrinol (OXF). 2000 Nov;53(5): 561-8 Villareal DT et al.
P. 152: DHEA improves bone density in spine: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2986-93 Jankowski CM et al.
P. 152: DHEA decreases bone loss: 

Cell Mol Immunol. 2006 Feb;3(1): 41-5 Wang YD et al.
P. 152: DHEA necessary for high-altitude acclimation: 

High Alt Med Biol. 2006 Fall;7(3): 228-36 Lee WC et al.
P. 152: DHEA affects sexual arousal and response: 

Fertil & Steril. 2002 Apr;77(4): S19-S25 Spark RF.
P. 152: DHEA megadose in double-blind studies showed increased sex drive and better orgasmic response: 

J Womens Health Gend Based Med. 2002 Mar;11(2): 155-62 Hackbert L et al.
P. 153: DHEA increases HGH: 

Clin Endocrinol. (OXF). 2006 Nov;65(5): 673-80 Brooke AM et al.; Fertil and Steril. 2001 Aug;76(2)241-248 Genazzani AL et al.
P. 153: DHEA increases allopregnenolone and endorphins: 

Fertil Steril. 2003 Dec;80(6): 1495-501 Genazzani AD et al.
P. 153: DHEA converts into estrogen: 

Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 153: DHEA increases progesterone levels: 

Maturitas. 2003 Jul 25;45(3): 231-5 Nadjafi-Triebsch C et al.
P. 153: DHEA reduces cortisol: 

Encephale. 2002 Mar-Apr;28(2): 139-46 Boudarene M et al.; Acta Psychiatr Scand. 2006 Sep;114(3): 187-93 Yehuda R et al.; J Clin Endocrinol Metab. 1996 Nov;81(11): 3951-60 Guazzo EP et al.
P. 153: DHEA decreases high levels of cortisol: 

Encephale. 2002 Mar-Apr;28(2): 139-46 Boudarene M et al.
P. 154: Women with adrenal deficiency and low cortisol tolerate higher levels of DHEA: 

Treat Endocrinol. 2005;4(2): 95-114 Cameron DR et al.
P. 154: DHEA can correct Graves’ Disease and Hashimoto’s Thyroiditis: Eur J Endocrinol. 2005 May;152(5): 

703-12 Solerte SB et al.
P. 154: DHEA decreases hot flashes: P.

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.
P. 154: DHEA reduces middle ear infections: 

J Pharmacol Sci. 2005 Oct;99(2): 191-4 Tabuchi K et al.
P. 154: DHEA improves fertility treatment in previously unresponsive women: 

Human Reprod. 2006 Nov;21(11)2845-9 Barad D et al.
P. 155: DHEA levels rise with the implementation of Natural Superwoman eating: 

Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46 Mattison JA et al.
P. 155: Study indicating that people with lower levels of DHEA were more likely to die during course of three year study: 

Ann Epidemiol. 2006 Jul;16(7): 510-5 Glei DA et al.
P. 157: Why studies that include women with Policystic Ovarian Syndrome are misleading?: 

Obstet Gnecol Surv. 2006 Nov;61(11): 723-32 Himelein MJ et al.; ARQ Bras Endocrinol Metab. 2005 Oct;49(5): 805-10 Spritzer PM et al.
P. 157: In women with Polycystic Ovarian Syndrome high level of DHEA are protective: 

Eur J Endocrinol. 2006 Jun;154(6): 883-90 Dagre A et al.
P. 157: Study reporting 17 women given 50 mg. DHEA with an absence of side effects, it makes no sense that they had no side effects: 

J Clin Endocrinol Metab. 1994 Jun;78(6): 1360-7 Morales AJ et al.
P. 158: Majority of studies on liver cancer treatment with DHEA show reduced proliferation: 

Int J Oncol. 2004 Oct;25(4): 1021-30 Mayer D et al.
158: Extremely high dose given for very long time to achieve negative effect: 

Cancer Lett. 1997 Dec 23;121(2): 125-31 Metzger C et al.
P. 160: Sublingual DHEA administration: 

Climacteric. 2003 Jun;6(2): 104-11 Wren BG et al.
P. 160: Benefits of micronized form of DHEA: 

Am J Obstet Gynecol. 1996 Feb;174(2): 649-53 Casson PR et al.
P. 162: Opposite-than-expected response is usually due to low Norepinephrine levels: 

Neuroscie Lett. 1996 Feb 9;204(3):181-4 Liu PS et al.
P. 163: Ginseng enhances DHEA effectiveness: 

CMAJ. 2006 Apr 11;174(8): 1134 Howard JM.

P. 165: High doses of Pregnenolone prescribed as miracle drug for Rheumatoid Arthritis in 1950s: 

J Lancet1950 Jul;70(7):264-5 Cohen A et al.
P. 165: Pregnenolone historically regarded as “mother of all hormones”: 

J Steroid Biochem Mol Bioc. 1991;40(1-3):71-81 Akwa Y et al.
P. 166: Pregnenolone gives more alert feeling by suppressing GABA: 

Acta Physiol (OXF). 2006 Nov;188(3-4):153-62 Wang MD et al.
P. 166: Pregnenolone protects from negative effects of increased glutamate by increasing dopamine: 

Pharmacol Biochem Behav. 2004 Aug;78(4):781-6 Maciejak P et al.
P. 166: Pregnenolone protects brain cells from Amyloid Beta Protein that is associated with alzheimer: 

Neurochem Res. 2001 Jan;26(1):15-21 Gursog et al.
P. 166: Less frequently the beta form of pregnenolone increases GABA: 

J Clin Endocrinol Metab. 2006 Aug;91(8):3092-9 Havlikova H et al.
P. 166: Pregnenolone increases capacity for cognitive function: 

Pharmacol Biochem Behav. 2004 Aug;78(4):781-6 Maciejak P et al.; Neuroscience. 2005;133(1):147-57 Shirayama Y et al.
P. 166: Pregnenolone improves new brain cell generation: Prog Neurobiol. 2003 Sep;71(1):43-8 Mayo W et al.
P. 166: Pregnenolone supports over-all memory by increasing acetylcholine: 

Brain Res. 2000 Jan 3;852(1):173-9 Darnaudery M et al.; Prog Neurobiol. 2003 Sep;71(1):43-8 Mayo W et al.
P. 166: Pregnenolone specifically increases spatial memory: 

J Neuroscience. 2006 Oct 25;26(43):11034-40 Yau JL et al.
P. 166: Pregnenolone increases memory in the aged: 

Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12 Vallee M et al.
P. 166: Prozac or Fluoxetine increase level of pregnenolone in brain: 

Pharmacol Biochem Behav. 2006 Aug;84(4):609-17 Marx CE et al.
P. 168: Drinking alcohol increases pregnenolone in brain: 

Psychopharmacology. 2006 Jun;186(3):451-61 Pierucci-Lagha A et al.
P. 168: Our body increases pregnenolone when sedative medication is taken: 

Psychneuroendocrinology. 2004 May;29(4):486-500 Meieran Se et al.
P. 170: People with social-phobias have naturally low levels of pregnenolone: 

Psychol Med. 2002 Jul;32((5):929-33 Heydari B et al.
P. 170: Pregnenolone is found in concentrated levels in the eye: 

Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12 Vallee M et al.
P. 171: 500mg daily of pregnenolone were prescribed in 1950s with no side effect: 

J Lancet. 1950 Jul;70(7):264-5 Cohen A et al.
P. 171: Studies indicate presence of pregnenolone decreases cholesterol levels as a complete HRT program: 

Med Hypoteses. 2002 Dec;59(6):751-6 Ozugan SA et al.; Gastroenterology. 1984 Aug;87(2):284-92. Turley SD et al.
P. 171: Pregnenolone plays important role in embryonic process: 

Nature. 2006 Jan;439(7075):480-3 Hsu HJ et al.

P. 178: Testosterone level in the cell and tissue not blood tell us how much testosterone you have: 

Endocr Rev. 2003 Apr;24(2):152-82 Labrie F et al.; Endocrine Reviews. 2005 May;26(3):322-330. Simpson EL et al.
P. 178: Testosterone in a women’s body is attached to sex hormone binding globulin: 

Zentralbl Gynakol. 1995;117(10):504-7. Schindler AE.
P. 179: Women’s testosterone expression peaks in early 20s and decreases nearly 50% by mid-forties: 

Sex Health. 2006 May;3(2):73-8. Burger HG et al.
P. 179: 2007 report warned about “substantial, yet-unrecognized” recent decline in men testosterone blood level: 

J Clin Endo & Metab. Jan;92(1):196-202. Thomas G et al.
P. 181: Animal research shows specific areas of brain directly responding to testosterone: 

Front Neuroendocrinol. 1996;17(1):51-125. Panzica GC et al.
P. 181: Testosterone has been shown to benefit sexuality of women who haven’t undergone hysterectomy or removal of ovaries: 

Menopause. 2006 Sep-Oct;13(5):770-9 Shifren JL et al.
P. 181: Women with hysterectomy on estrogen benefit significantly with testosterone treatment:
P. 182: Testosterone significantly reduced women’s fear response: 

Biol Psychiatry. 2006 May 1;59(9):872-4 Hermans EJ et al.
P. 183: Testosterone supplementation has positive affect on depression: 

Climacteric. 2004 Dec;7(4):338-46 Studd J et al.
P. 183: Estrogen improves depression and sexual response: 

J Obstet Gynaecol Res. 2005 Apr;31(2):107-14 Nagata H et al.
P. 184: Addition of testosterone to men who take SSRI(Prozac) improved depression and sexual functions: 

J Affect Disord. 1998 Mar;48(2-3):157-61 Seidman SN et al.; J Clin Psychiatry. 2005 Nov;66(11):1409-14 Nelson JC et al.
P. 184: Testosterone combined with estrogen and Melatonin alleviates cluster headaches: 

Headache. 2006 Jun;46(6):925-33 Stillman MJ.
P. 184: Testosterone known as a bone-builder: 

Gynecol Endocrinol. 2005 Mar;20(3):155-60 Floter A et al.; Clin Endocrinol (Oxf). 2004 Nov;61(5):560-6. Turner A et al.; Maturitas. 2004 Jul 15;48(3):235-42 Tok EC et al.; Br J Obstet Gynaecol. 1992 Sep;99(9):757-60 Savvas M et al.; J Clin Endocrinol Metab. 1996 Jan;81(1):37-43 Raisz LG et al.
P. 184: Testosterone neuroprotective in treatment of MS in men: 

Arch Neurol. 2007 May;64(5):683-8 Sicotte NL et al
P. 185: Women undergoing IVF enjoy improved results when testosterone is added: 

Hum Reprod. 2006 Jul;21(7):1884-93 Balasch J et al
P. 185: Testosterone supports follicle function: 

Hum Reprod. 2006 May;21(5):1204-11 Massin N. et al
P. 185: Decreased testosterone levels associated with increase cardiovascular disease in menopause: 

Coron Artery Dis. 2007 feb;18(1):9-13 Montalcini T et al.
P. 185: Decreased testosterone in menopause increases thickness of carotid artery wall: 

J Clin Endocrinol Metab. 1999 Jun;84(6):2008-12 Bernini GP et al.
P. 185: Decreased testosterone associated with increase atherosclerosis: 

Eur J Endocrinol 2007 Jun;156(6):689-93. Debing E et al.
P. 185: Mice treated with testosterone show improvement in coronary artery function: 

Fertil Steril. 2006 Oct 31; Cooper BC et al
P. 186: Female-to-male transsexuals do not experience change in mortality: 

Metabolism. 1989 Sep;38(9):869-73 Asscheman H et al..
P. 186: Testosterone treatment helpful in preventing and treating diabetes: 

Int J Impot Res. 2006 Jul 20; Svartberg J.
P. 186: Women with polycystic ovaries and testosterone: 

Fertil Steril, 2006 Mar;85(3):679-88
P. 186: In female-to-male transsexuals large doses of testosterone have no affect on insulin sensitivity: 

Clin Endocrinol (Oxf). 2003 May;58(5):562-71 Elbers JM et al.
P. 186: Female HIV patients treated with high dose testosterone evidence no change in insulin sensitivity: 

Fertil Steril. 2006 Jun;85(6):1794-802. Herbst KL et al.
P. 186: Testosterone protects against breast cancer: 

Endocr Rev. 2003 Apr;24(2):152-82. Labrie F et al.; Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.; Menopause. 2007 Mar-Apr;14(2):183-90. Hofling M et al.
P. 186: Testosterone Protects breast cancer by decreasing breast tissue proliferation: 

Menopause. 2007 Mar-Apri;14(2):183-90 Hoflin M et al.
P. 187: Women to men transexuals have breasts like old postmenopausal women: 

J Histochem Cytochem. 2006 Aug;54(8):905-10. Stagter MH et al.
P. 187: Historically testosterone was the treatment of choice for breast cancer:
Eur J Surg Oncol. 1987 Apr;13(2):113-7. Karydas I et al.
P. 188: Oral contraceptives decrease close to 80% of the available testosterone: 

Contraception. 1999 Nov;60(5):255-62. Thorneycroft IH et al.; Acta Derm Venereol. 1984;64(6):517-23. Palatsi R et al.
P. 189: Mortality rates nearly 50% higher in women who remove their ovaries before age 45: 

Lancet Oncol. 2006 Oct;7(10):821-8. Rocca WA et al.
P. 189: Women lose 70% of testosterone within 72 hours after removal of their ovaries: 

Maturitas. 2002 Apr 15;41. Rohr UD.
P. 190: Premarin known to increase level of sex-binding globulin: 

Zentralbl Gynakol. 1995;117(10):504-7. Schindler AE.
P. 190: Women lose sexual drive and function from anti depressive medication and SSRI: 

NJ Clin Psychiatry. 2001;62 Suppl 3:22-34. Ferguson JM.; Psychother Psychosom. 2006;75(3):187-8. Csoka Ab et al.
P. 190-191: Metyl-testosterone is toxic to liver: 

N Engl J Med. 1952 Jan 31;246(5):176-9. Brick IB et al.; Ann Intern Med. 1954 Jan;40(1):146-52. Almaden PJ et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Am J Med. 1950 Mar;8(3):325-31. Werner SC et al.; Toxicology. 1977 Jun;7(3):357-65. Heywood R. et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Gastroenterology. 1956 Oct;31(4):384-90. Kaplan AA.
P. 191: There is no established normal blood level for testosterone in women: 

Curr Opin Urol. 2002 Nov;12(6):503-7. Anastasiadis AG et al.
P. 191: Many tests yield falsely high results: 

NAnn Clin Biochem. 2007 Jan;44(Pt 1):5-15. Kane J et al.
P. 191: Because of sloppy testing medical authorities have concluded that it is not possible to make educated assessment about existence of androgen deficiency: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: Testosterone expression is determined by levels in cells and tissues (targets): 

Endocr Rev. 2003 Apr;24(2):152-82. Labrie F et al.
P. 191: Measure of sexual response is not based on blood level: 

J Sex Med. 2005 May;2(3):291-300. Basson R et al.
P. 191: FDA and various medical associations contend women cannot benefit from testosterone supplementation: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: Bioidentical testosterone in pill form decreases women’s level of HDL and fails to yield as good results as other forms: 

Growth Horm IGF Res. 2006 Jul;16 Suppl A:S109-17. Braunstein GD.; J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: In US women can get Metyl-testosterone which has found to be toxic to liver: 

N Engl J Med. 1952 Jan 31;246(5):176-9. Brick IB et al.; Ann Intern Med. 1954 Jan;40(1):146-52. Almaden PJ et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Toxicology. 1977 Jun;7(3):357-65. Heywood R et al.; Am J Med. 1950 Mar;8(3):325-31. Werner SC et al.; Gastroenterology. 1956 Oct;31(4):384-90. Kaplan AA.
P. 192: Sublingual testosterone reaches effect in 15 minutes and restores levels within two hours: 

Arch Gen Psychiatry. 2000 Feb;57(2):149-53. Tuiten A et al.
P. 192: Vaginally applied testosterone cream or gel peaks at 5.5 hours and lasts more than 12: 

J Sex Med. 2006 May;3(3):541-9. Apperloo M et al.
P. 196: Caffeine may counteract loss of head hair and chin hair growth from testosterone: 

J Sex Med. 2006 May;3(3):541-9. Apperloo M et al.
P. 196: Caution against use of Propecia: 

Nat Med. 2004 Jul;10(7):704-11. Griffin LD et al.; Semin Cell Dev Biol. 2004 Aug;1594):445-54. Ikonen E et al.

P. 212: Stress produces cardiovascular deterioration: 

PNAS. 1997;94:P9960 et al.; J Nutr Health Aging. 2004;8(3):163-74. Bourre JM et al.; J Med Genet. 2006 Oct;43(10):e52. Lehmann DJ et al.; FEBS Lett. 2006 Dec 11;580(28-29):6730-40. Lu J et al.
P. 212: Oxidative Stress markers decrease immunity: 

Neurology. 2006 Oct 24;67(8):1370-6. Morris MC et al.; J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.
P. 212: Chronic activation of stress response leads to wear and tear and predisposes to disease: 

Proc Biol Sci. 2006 Apr 7;273(1588):881-5. Hadany L et al.
P. 212: Stress elevates blood pressure: 

J Hum Hypertens. 2003 Dec;17(12):829-40. Schneider GM et al.; Croat Med J. 2006 Jun;47(3):416-23. Santic Z et al.
P. 212: Stress increases memory loss: 

FASEB J. 2006 Apr;20(6):729-31. Jeong YH.; J Neurosci. 2006 Mar 22;26(12):3309-18. Son GH et al.; Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD.; Biol Psychiatry. 2006 Oct 1;60(7):722-9. Morgan CA et al.
P. 212: Stress increases Oxidative Stress: 

Rinsho Byori. 2005 Feb;53(2):155-9. Shioji I.; Biochem Biophys Res Commun. 2006 Oct 20;349(2):775-80. Miyashita T et al.
P. 212: Stress increases risk of breast cancer: 

Am J Epidemiol. 2003 Mar 1;157(5):415-23. Lillberg K et al.
P. 212: Stress increases back pain: 

J Occup Environ Med. 2006 Jun;48(6):607-14. Feuerstein M et al.
P. 212: Stress increases headache: 

Headache. 2006 Oct;46(9):1377-86. Nash JM et al.
P. 212: Stress increases hair loss: 

Dermatology. 2006;213(1):44-5. Atefi N et al.
P. 212: Holding breath shown to reduce oxidative stress and acidity in blood: 

Respir Physiol Neurobiol. 2002 Oct 23;133(1-2):121-30. Joulia F et al.
P. 220: Women with chronic fatigue syndrome show adrenal glands decreases 50%: 

Cell Mol Biol Lett. 2005;10(4):669-76. Haider S et al.
P. 223: Yoga and meditation improve endo thelial function: 

Clin Cardiol. 2006 Sep;29(9):393-8. Sivasankaran S.
P. 225: DHEA counterbalances negative affects of high cortisol: 

Treat Endocrinol. 2005;4(2):95-114. Cameron DR.; Encephale. 2002 Mar-Apr;28(2):139-46. Boudarene M et al.
P. 225: DHEA increases progesterone, alloprenenolone, and endorphin production: 

Fertil Steril. 2003 Dec;80(6):1495-501. Genazzani AD et al.
P. 226: Melatonin lowers levels of nighttime cortisol and avoid further adrenal deterioration: 

Med Sci Monit. 2005 Jun;11(6):CR284-288. Mazzoccoli G et al.; J Physiol. 2004 Feb 1;554(Pt 3):841-56. Torres-Farfan C et al et al.
P. 226: Women in Adrenal Over-Production group can benefit by correcting HGH deficiency: 

Neuroscience. 2004;123(2):429-40. Molteni R et al.
P. 228: Hydrocortisol can bridge body’s need for cortisol while adrenal gland recovers: 

Journal Clinic Endo & Metab. 2001 Aug;86(8):3545-3554. Cleare AJ et al.; Psychophysiology. 2006 Nov;43(6):653-6. Tops M et al.

P. 246: SAMe can be efficient anti-depressant: 

Acta Neurol (Napoli). 1978 May-Jun;33(3):243-55. Miccoli L et al.; Am J Clin Nutr. 2002;76(5):1158S-1161S. Mischoulon D et al.

P. 273: Definition of insomnia: 

Am J Med. 2006 Jun;119(6):463-9. Kamel NS et al.
P. 273: 10% of Americans suffer from insomnia; 25-35% suffer occasionally: 

Am J Manag Care. 2006 May;12(8 Suppl):S214-20. Doghramji K.
P. 274: Insomnia afflicts more women; more so as they age: 

Am J Med. 2006 Jun;119(6):463-9. Kamel NS et al.
P. 275: Body does not allow sleep when under stress: 

Psychosom Med. 2003 Mar-Apr;65(2):259-67. Morin CM et al.
P. 276: Abnormal sleep patterns correlate to lower life expectancy: 

Am J Manag Care. 2006 May;12(8 Suppl):S214-20. Doghramji K.
P. 276: One third to half of insomniacs suffer from mood disorders and substance abuse: 

Sleep Med rev. 2000 Jun;4(3):253-262. Lustberg L et al.; Sleep Med Rev. 1997 Nov;1(1):45-56. Benca RM et al.
P. 276 Sleep disorders increase incidents of cardiovascular disease and related death: 

J Psychosom Res. 1999 Oct;47(4):313-33. Schwartz S et al.; Ann Epidemiol. 1998 Aug;8(6):384-92. Schwartz SW et al.
P. 276: Sleep deficiency may bring on/enhance depression: 

Sleep Med Rev. 2000 Jun;4(3):253-262. Lustberg L et al.
P. 277: Stress and anxiety can enhance insomnia: 

Psychosom Med. 2003 Mar-Apr;65(2):259-67. Morin CM et al.
P. 277: Insomnia enhance headaches: 

Sleep Med Rev. 2002 Dec;6(6):471-9. Jennum P.
P. 281: Estrogen and progesterone should be first line of defense against insomnia: 

J Br Menopause Soc. 2004 Dec;10(4):145-50. Polo-Kantola P et al.
P. 282: Melatonin found throughout the natural world: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.
P. 282: Melatonin hormone produced in retina, gastrointestinal tract, skin, bone marrow and lymphocytes: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.
P. 282: Melatonin is free-radical scavenger: 

Comb Chem High Throughput Screen. 2006 Jul;9(6):409-19. Suzen S.; FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.; J Endocrinol Invest. 2006 Mar;29(3):281-7. Aydogan S et al.; Behav Brain Funct. 2006 May 4;2(1):15. Srinivasan V et al.; Biosci Rep. 2007 Sep 7 7; Maharaj DS et al.; J endocrinol. 2007 Sep;194(3):637-43. Rodriguez MI et al.
P. 282: Melatonin deficiency increase weight gain and depression: 

J Soc Biol. 2007;
201(1):105-13. Guardiola-Lemaitre PB.
P. 282: Melatonin alleviates depression improving thyroid function: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.; J Psychiatry Neurosci. 2000
P. 283: Melatonin decreases anxiety: 

Prog Neuropsychopharmacol Biol Psychiatry.
2000 Jan;24(1):117-29. Naranjo-Rodriguez EB et al.
P. 283: Melatonin promotes blood platelets health: 

Neuro Endocrinol Lett. 2006 Aug 5;27(4). Bella LD.
P. 283: Melatonin prevent post surgical adhesions: 

Yonsei Med J. 2007 Aug 31;48(4):659-64. Hatipoglu A et al.
P. 283: In ulcerative colitis, melatonin repairs damage to the mucosal of the GI system: 

Dig Dis Sci. 2006 Sep;51(9):1538-45. Necefli A et al.
P. 283: Melatonin repair duodenal ulcer: 

Klin Med (Mosk). 2006;84(1):5-11. Malinovskaia N K et al.
P. 283: Melatonin repair acute esophageal ulcer; J Physiol Pharmacol. 2007 Jun;58(2):361-77. Konturek SJ et al.
P. 283: Melatonin maybe the future treatment for all acid reflux problems: 

Pol Merkur Lekarski. 2007 May;22(131):332-5. Walecka-Kapica E et al.
P. 283: Melatonin helps heal tinnitus: 

Otolaryngol Head Neck Surg. 2006 Feb;134(2):210-3. Megwalu UC et al.
P. 283: Melatonin may protect from ALS: 

J Pineal Res. 2006 Nov;41(4):313-23. Weishaupt JH et al.
P. 283: Melatonin may protect from Alzheimer’s; Behav Brain Funct. 2006 May4;291):

15. Srinivasan V et al.
P. 283: Melatonin helps alleviate hypertension: 

Am J Hypertens. 2005 Dec;18(12 Pt 1):1614-8. Cagnacci A et al.
P. 283: Melatonin decrease endometriosis: 

Fertil Steril. 2007 Jun 18; Guney M et al.
P. 283: Melatonin boosts and improves immune system: 

Med Sci Monit. 2006 Aug 25;12(9): BR307-312. Ergun Y et al.; Mol Cell Biochem. 2006 Aug 24. Cubero J et al.; Expert Opin Invest 16 Drugs. 2001 Mar;10(3):467-76. Maestroni GJ et al.
P. 284: Melatonin reduces cholesterol levels: 

Nuero Endocrinol Lett. 2002 Apr;23(1):79-83. Sewerynek E.
P. 284: Melatonin decreases brain vascular damage: 

Neurosci Lett. 2002 Feb 1;318(3):141-4.
P. 284: Meltatonin is used for treating cluster headaches: 

Curr Pain Headache Rep. 2006 Apr:10(2):147-52. Sillman M.
P. 284: Women with lower levels of melatonin are more likely to suffer migraines: 

CNS Drugs. 2006;20(5):343-50. Vogler B et al.
P. 284: Melatonin treatmet for migraines: 

CNS Drugs. 2006;20(5):343-50. Vogler B et al.
P. 284: Melatonin increases glutathione formation: 

Neuro Endocrinol Lett. 2006 Jun 2;27(3). Swiderska-Kolacz G et al.
P. 284: Melatonin protects kidney from damage caused by kidney infection: 

Urology. 2006 Jun;67(6):1315-9. Imamoglu M et al.
P. 284: Melatonin improves and resolves dry eye syndrome: 

Eur J Pharmacol. 2006 Dec 15;552(1-3):159-61. Hoyle CH et al.
P. 284: Melatonin helps combat damaging effect of high blood sugar: 

Acta Histochem. 2006;108(2):85-93. Guven A et al.
P. 284: Melatonin protects against osteoporosis: 

J Pineal Res. 2003 Mar;34(2)143-51. Ladizesky MG et al.
P. 285: Melatonin inhibits proliferation and metastasis of cancerous tumors: 

Cancer Detect Prev. 2006;30(2):118-28. Cos S et al.
P. 285: Melatonin may protect from pancreatic cancer: 

J Pineal Res. 2007 Oct;43(3):270-5. Ruiz –Rabelo JF et al.
P. 285: Melatonin increases efficacy and decreases side effect of chemotherapy: 

Cancer Res. 2006 Oct 15;66(20):9789-93. Jung B et al.
P. 285: Melatonin acts as a natural aromatase inhibitor: 

J Pineal Res. 2005 Mar;38(2):136-42. Cos et al.
P. 285: Melatonin and Vitamin D-3 increases the realease of TGF Beta 1, reduce growth of breast cancer: 

J Surg Res. 2003 Apr;110(2):332-7. Bizzarri M et al.
P. 285: Melatonin is able to reverse the decline and rise of hormonal function associated with aging: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.
P. 286: In post-menopausal women, melatonin suppresses rise of LH: 

BMC Womens Health. 2006 May 16;6:8. Kripke DF et al.
P. 286: Increase of FSH and LH is first sign of decreased ovarian function and an aging hormonal system: 

BMC Womens Health. 2006 May 16;6:8. Kripke DF et al.
P. 286: Six-month treatment with melatonin changes gonadotropin: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.
P. 286: Melatonin in high doses has contraceptive effects: 

Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):3-9. Silman RE et al.
P. 286: Melatonin improves brain’s response to inflammation: 

J Neuroimmunol. 2006 Oct 27. Perreau VM et al.
P. 286: Melatonin helps with jet-lag: 

Uqeskr Laeger. 2001 Jan 8;163(2):149-55. Christiansen AL et al.; Chochrane Database Syst Rev. 2002;(2):CD00152. Herxheimer A et al.; BMJ. 1989 Mar 18;298(6675):705-7. Petrie K et al.; J Mol Microbiol Biotechnol. 2002 Sep;495):463-6. Parry BL.
P. 286: Melatonin significant sleep aid: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.; J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):233-41. Van der Heijden KB et al.; Z Gerontol Geriatr. 2001 Dec;34(6):491-7. Olde Rikkert MG et al.; Curr Med Res Opin. 2007 Sep 14; Wade AG et al.
P. 287: Using Melatonin with Arginine to decrease oxidative damage of NO: 

J Endocrinol Invest. 2006 Mar;29(3):281-7. Aydogan S et al
P. 287: Melatonin help fertility: 

J Pineal res. 2007 Oct;43(3):283-8. Rodriguez-Osorio N et al.

P. 295: Insulin resistance increase levels of GSK-3, that is destructive to the brain ultimately causing apastosis: 

Exp Gerontol. 2007 Jan-Feb;42(1-2):10-21. Cole GM et al.
P. 295: Women with Alzheimer’s have increased levels of GSK-3: 

Eur J Neurosci. 2007 Jan;2591):81-86. Hooper C et al.
P. 295: Memory and brain function of women with diabetes more likely to have memory and brain function problems: 

J Diabetes Complications. 2006 Jul-Aug;20(4):238-45. Debling D et al.
P. 296: Adults with Type 2 Diabetes evidence better cognitive performance following just one low glycemic index, low carbohydrate meal: 

Diabetologia. 2006 May;49(5):855-62. Papanikolaou Y et al.
P. 296: Diet that promotes insulin resistance proven to promote alzheimer: 

FASEB J. 2004 May;18(7):902-4. Ho L et al.; Exp Gerontol. 2007 Jan-Feb;42(1-2):10-21. Cole GM et al.
P. 296: Fruit has higher glycemic index and does not help the brain: 

Neurology. 2006 Oct 24;67(8):1370-6. Morris MC et al.
P. 297: DHEA increases AKT-PI3K that protect the brain: 

Brain Res Mol Brain Res. 2002 Jan 31;98(1-2):58-66. Zhang L et al.
P. 297: Melatonin increases AKT-PI3K: J Pineal Res. 2006 Jan;40(1):79-85. Lee SH et al.
P. 297: Memantine/Galatamine promotes memory and decreases GSK-3 that is destructive to the brain: 

Neurobiol Aging. 2006 Mar;27(3):413-22. De Sarno P et al.
P. 298: The scientific community did not believe that our diet can influence brain function: 

J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.
P. 298: Omega-3 deficient diets can cause structural abnormalities and a decline in cognitive function: 

J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.; J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 298: High fat and refined sugar reduces BDNF that is the key to proper brain function: 

Neuroscience. 2002;112(4):803-14. Molteni R et al.
P. 298: Consuming saturated and trans-fats lower cognitive function: 

Neurology. 2004 May 11;62(9):1573-9. Morris MC et al.
P. 298 Diets high in saturated fasts have been shown to aggravate outcome of tramatic brain injuries: 

Neuroscience. 2003;119(2):365-75. Wu A et al.
P. 298: Studies indicate that it doesn’t take long for unfavorable fats to have negative effect on cognitive function: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 299: Positive effects of vitamin and minerals on brain activity: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 299: Vitamin B-1 (Thiamine) improves cognitive function: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 299: Vit C is found in high concentration in brain nerve ending: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; Am J Geriatr Psychiatry. 2006 Dec;14912):1032-40. Wilkins CH et al.
P. 299: Vitamin D plays an important role in nerve tissue chemistry: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 300: Vitamin E protects the brain membrane: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; Arch Neurol. 2002 Jul;59(7):1125-32. Morris MC et al.
P. 300: Vitamin K plays an important role in nerve tissue chemistry: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 300: Lipoic Acid provides core brain function protection: 

Pharmacol Ther. 2007 Jan;113(1):154-64. Holmquist L et al.; Neurobiol Aging. 2007 Feb;28(2):213-25. Quinn JF et al
P. 301: Iron is necessary for oxygenation and energy production: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 301: Iron levels that are too high increase free radicals and risk of Alzheimer’s disease: 

J Med Genet. 2006 Oct;43(10):e52. Lehmann DJ et al.
P. 301: Magnesium is essential for synaptic transmission, brain enzymatic and brain cell activity: 

Magnes Res. 2006 Sep;19(3):199-215. Billard JM.; Clin Calcium. 2004 Aug;14(8):60-4. Enomoto T et al.
P. 301: Magnesium given before open heart surgery decreases cognitive decline: 

J Thorac Cardiovasc Surg. 2006 Apr;131(4):853-61. Bhudia SK et al.
P. 301: Zinc taking patients experience improvement in spatial working and visual memory: 

Br J Nutr. 2006 Oct;96(4):752-60. Maylor EA et al.
P. 301: Excess heavy metals have no place in the body and are destructive to the memory: 

Cell Molk Biol Lett. 2005;10(4):669-76. Haider S et al.; Occup Environ Med. 2005 Mar;62(3):181-7. Bleecker ML et al.; J Occup Environ Med. 2005 Sep;47(9):902-8. Chen SS et al.; Neurotoxicology. 2006 Mar;27(2):291-5. Tsai YT et al.
P. 301: Taurine protects from lead toxicity while improving neuron-transmitter production: 

Neuroscience. 2005;134(1):215-24. Zhu DM et al.
P. 304: Phosphatidylserine found in inner leaflet of brain cell membrane: 

Sports Med. 2006;36(8):657-69. Kingsley M.
P. 304: Phosphatidylserine plays role in maintaining proper function of brain cell membranes: 

Isr J Psychiatry Relat Sci. 2000;37(4):302-7. Schreiber S et al.
P. 304: Phosphatidylserine increases acetyl cholin: 

J Nutr. 2001 Nov;131(11):2951-6. Suzuki S et al.; Jpn J Pharmaacol. 1997 Dec;75(4):447-50. Furushiro M et al.
P. 304: Phosphatidylserine increases serotonin: 

Jpn J Pharmaacol. 1997 Dec;75(4):447-50. Furushiro M et al.
P. 304: Phosphatidylserine improves memory within six weeks: 

Isr J Psychiatry Relat Sci. 2000;37(4):302-7. Schreiber S et al.; Neurology. 1991 May;41(5):644-9. Crook TH et al.
P. 304: Phosphatidylserine derived from soy lecithin may be superior to supplement with: 

Nutrition. 1999 Oct;15(10):778-83. Blokland A et al.
P. 304: Phosphatidylserine may decrease cortisol levels: 

Sports Med. 2006;36(8):657-69. Kingsley M.
P. 304: Acetyl-L-Carnitine can decrease free radical oxidative stress and improve spatial memory and overall cognitive function: 

J Neurosci Res. 2006 Aug 1;84(2):398-408. Abdul HM et al.; J Gerontol A Biol Sci Med Sci. 1995 Jul;50(4):B232-36. Caprioli A et al.; Drugs Exp Clin Res. 1994;20(4):169-76. Salvioli G et al.
P. 305: Ginko Biloba improves memory by suppressing and reversing amyloid beta: 

J Neurosci. 2006 Dec 13;26(50):13102-13. Wu Y et al.; Planta Med. 2006 Nov;72(14):1296-9. Brunetti L et al.
P. 305: Ginko protects brain cells from effects of NMDA: 

Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2479-84. Xiao ZY et al.
P. 305: Ginko increases brain oxygen supply, promotes antioxidant production, and production of free radicals: 

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Sep;26(9):795-8. Deng YK et al.
P. 305: Ginko shown to prevent age-related memory loss: 

Exp Neurol. 2003 Nov;184(1):510-20. Stackman RW et al.
P. 305: Ginko increased positive performance in Alzheimer’s patients at least as good as common drug without the drug side effect: 

Eur J Neurol. 2006 Sep;13(9):981-5. Mazza M et al.
P. 305: Ginko protect from ovarian cancer: 

Cancer Lett. 2006 Dec 26; Ye B et al.
P. 306: Huperzine A acts as a acetylcholinesterase inhibitor: 

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Wang R et al.
P. 306: Huperzine has been shown to improve memory in adults with mild memory loss and in patients with Alzheimer’s: 

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Wang R et al.
P. 306: Vinpocentine is used to treat memory loss associated with cerebrovascular cognitive diseases: 

Eur J Pharmacol. 1990 Oct 23;187(3):551-3. Erdo SL et al.
P. 306: Vinpocentine protects brain cell from cell destruction: 

Eur J Pharmacol. 1990 Oct 23;187(3):551-3. Erdo SL et al.; Ideggyogy Sz. 2003 May 20;56(5-6):166-72. Hadjiev D.
P. 307: Galantamine effective in Alzheimer’s patients: 

Cochrane Database Syst Rev. 2002;(3):CD001747. Olin J et al.; Drugs Aging. 2003;20(10):777-89. Wilcock G et al.
P. 307: Galantamine more effective and non toxic compare to drug (Aricept) for treatment of memory loss: 

Drugs Aging. 2003;20(10):777-89. Wilcock G et al.
P. 307: Wide use of Galantamine as remedy for mild memory loss: 

Cochrane Database Syst Rev. 2002;(3):CD001747. Olin J et al.
P. 308: Hydergine helpful at improving memory loss: 

Arch Neurol. 1994 Aug;51(8):787-98. Schneider LS et al.; Curr Med Res Opin. 1986;10(4):256-79. Huber F et al.
P. 308: Hydergine is an MAO inhibitor: 

Eur Neuropsychopharmacol. 1995 Dec;5(4):527-9. Buyukozturk A et al.
P. 308: Aniracetam improves memory by increasing supply of PI3: 

Eur J Pharmacol. 2004 Jun 28;494(2-3):111-20. Gabryel B et al.
P. 308: Aniracetam increases dopamine and serotonin levels: 

Brain Res. 2001 Oct 19;916(1-2):211-21. Shirane M et al.; Pharmacol Biochem Behave. 2001 Jan;68(1)65-9. Nakamura K et al.; Brain Res Brain res Rev. 1994 May;19(2):180-222. gouliaev AH et al.
P. 308: Piracetam improve vertigo and dyslexia: 

CNS Drug Rev. 2005 Summer;11(2):169-82. Winblad B.
P. 308: Piracetam has shown to improve learning and memory in health adults: 

Psychopharmaco. 1976;49:307-09. Dimond SJ et al.
P. 308: Piracetam reverse memory loss from electric shock and barbiturate intoxication: 

Brain Res Brain res Rev. 1994 May;19(2):180-222. Gouliaev Ah et al.
P. 308: In extreme cases, Aniracetam and Piracetam shown to improve memory loss: 

Neuroprotection. May 20;56(5-6):166-72. Haddjiev D et al.
P. 308: Centrophenoxine improves memory by reducing lipofuscion: 

Neurobiol Aging. 1986 Mar-Apr;7(2):107-13. Andrews LD et al.; J Gerontol. 1983 Sep;38(5):525-31. Katz ML et al.
P. 308: Centrophenoxine reverses aluminum toxicity associated with Alzheimer’s: 

Mol Cell Biochem. 2006 Oct;290(1-2):185-91. Nehru B et al.
P. 310: Suboptimal thyroid levels associated with severe brain atrophy: 

Neuroepidemiology. 2006;27(2):89-95. Reitz C et al.
P. 310: Addressing thyroid definiciency improves cognitive function and verbal memory: 

Int J Neurosci. 2006 Aug;116(8):895-906. Miller KJ et al.
P. 310: Melatonin inhibits generation of beta-amyloid and tau hyperphosphorylation: 

Acta Pharmacol Sin. 2006 Jan;27(1):41-9. Wang JZ et al.
P. 310: DHEA and testosterone protect against Alzheimer’s: 

J Neurosci. 2002 Jun 15;22(12):5204-9. Raber J et al.
P. 311: Testosterone supplementing can improve women’s visual and spatial memory: 

Psychoneuroendocrinology. 2004 Jun;29(5):612-7. Aleman A et al.
P. 311: Bioidentical progesterone improves memory by calming, improving sleep, and providing general cognitive protection: 

Ann N Y Acad Sci. 2005 Jun;1052:152-69. Stein DG.
P. 311: Progesterone shown to prevent damage caused by brain trauma and to enhance the rate of recovery: 

Neuroscience. 2004;123(2):349-59. Djebaili M et al.; Exp Neurol. 2002 Nov;178(1):59-67. Shear DA et al.
P. 311: Progesterone increase BDNF and protect against glutamate toxicity: 

J Neurosci Res. 2007 Jun 4;85(11):2441-2449. Kaur P et al.
P. 312: Pregnenolone stimulates brain cell production in hippocampus: 

Neurobiol Aging. 2005 Jan;26(1):103-14. Mayo W et al.
P. 312: Pregnenolone protects brain cells from glutamate and amyloid beta protein toxicity: 

Neurochem Res. 2001 Jan;26(1):15-21. Gursoy E et al.
P. 313: Human growth hormone is big help to the brain: 

Horm Res. 2005;64 Suppl 3:109-14. Van Dam PS.; Horm Res. 2005;64 Suppl 3:100-8. Maruff P et al.
P. 313: Removal of one or two ovaries before menopause increase cognitive decline: 

Neurology. 2007 Aug 29; Rocca WA et al.
P. 314: Physical activity improves learning, memory and overall cognitive function: 

Nutr Health. 2006;18(3):277-84. Pinilla FG.
P. 314: Treadmill running improves rate of brain cell production in hippocampus: 

Brain Res. 2006 Aug 9;1104(1):64-72. Uda M et al.
P. 314: Exercise improves negative effects of high fat diet: 

Nutr Health. 2006;18(3):277-84. Pinilla FG.; Neuroscience. 2004;123(2):429-40. Molteni R et al.
P. 314: Women between ages 59-68 improve cognitive performance after three months of exercise: 

J Physiol Pharmacol. 2006 Sep;57 Suppl 4:417-24. Zlomanczuk P et al.
P. 314: Combination of mental and aerobic training shows greater improvement than either alone: 

Int J Sports Med. 2002 Aug;23(6):415-21. Fabre C et al.
P. 315: Stress associated with brain atrophy: 

CNS Neurol Disord Drug Targets. 2006 Oct;5(5):503-12. Bremner JD.
P. 315: Brain shrinks as consequence of trauma: 

Biol Psychiatry. 2002 Jul 15;52(2):119-25. Villarreal G et al.
P. 315: More interpersonal stress adults experience, greater rate of memory failure on day-to-day basis: 

Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD et al.
P. 316: Studies indicate that yoga assist brain in healing: 

Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD et al.
P. 316: Studies indicate that praying assist brain in healing: 

Percept Mot Skills. 1999 Jun;88(3 Pt 1):765-70. Febbro F et al.
P. 316: Studies indicate that meditation assist brain in healing: 

Int J Clin Exp Hypn. 2004 Oct;52(4):434-55. Wagstaff GF et al.
P. 316: Tai Chi Chuan helpful after head trauma: 

Arch Phys Med Rehabil. 2001 Sep;82(9):1283-5. Shapira MY et al.
P. 316: Sleep depravation is chronic stress inducer: 

Metabolism. 2006 Oct;55(10suppl 2):S20-3. McEwen BS.
P. 316: Sleep depravation impairs spatial memory and impairs hippocampal function: 

Brain Res. 2004 Aug 20;1018(1):38-47. Guan Z et al.
P. 317: Resolving sleep apnea with use of PAP mask restores much of lost cognitive function: 

Chest. 2006 Dec;130(6):1772-8. Zimmerman ME et al.
P. 317: Association between depression and subsequent decline cognitive function: 

Arch Gen Psychiatry. 2006 Feb;63(2):130-8. Steffens DC et al.
P. 317: By incorporating four pillars, woman are able to improve cognitive function: 

Am J Geriatr Psychiatry. 2006 Jun;14(6):538-45. Small GW et al.

P. 321: Significant increase of osteoporosis and bone fracture when women stop to take estrogen: 

Climacteric. 2007 Aug;10(4):273-5. gambaccini M et al.
P. 321: Osteoporosis a major public health threat: 

Contracept Technol Update. 2000 Aug;21(8):95-6 et al.
P. 321: Poor diet, lack of vitamins and minerals and bone loss: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H.; Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.; Osteoporosis Int. 2006;17(7):1022-32. Rude RK et al.
P. 321: Bone loss due to inflammation: 

Inflamm Res. 2004 Nov;53(11):596-600. Haynes DR.
P. 321: Vitamin D prevent and treat bone loss: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H.; Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.
P. 321: Magnesium deficiency and bone loss: 

Osteoporosis Int. 2006;17(7):1022-32. Rude RK et al.; Ir J Med Sci. 2001 Jan 邦ar;170(1):58-62. O達rien M.
P. 321: Lack of exercise and bone loss: 

J Ir Med Sci. 2001 Jan-Mar;170(1):58-62. O達rien M.
P. 321: Use of very low-dose birth control pills may induce bone loss: 

Bone 2007 Feb;40(2):444-50. Hartard M et al.; Curr Opin Obstet Gynecol. 2003 Oct;15(5):353-7. Cromer BA.
P. 321: Use of Depo-Provera cause bone loss: 

Hong Kong Med J. 2005 Dec;11(6):491-5. Lo SS et al.
P. 321: Use of acid-blocking medications like Zantac and Nexium cause bone loss: 

JAMA. 2006 Dec 27;296(24):2947-53. Yang YX et al.
P. 321: Use of anti-depressants like Prozac and Zolof cause bone loss: 

Lakartidningen. 2005 Sep 26-Oct 2;102(39):2746-9. Lerner UH.
P. 322: Use of aromatase inhibitors cause bone loss: 

Oncologist. 2006 Nov-Dec;11(10):1058-69. Perez EA.; Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048. Perez EA et al.
P. 322: Risk of jaw bone necrosis with conventional osteoporosis medications: 

Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048. Perez EA et al.
P. 323: The longer the use of conventional osteoporosis medications, the more they accumulate and remain in the bones: 

J Clin Eno & Metab. 2005:90(3) 1897-1899. Ott SM.
P. 323: Fracturing bones while on Fosemax, Boniva may cause slow and inefficient healing: 

J Clinic Endo & Metab. 2005;90(3):1294-1301. Odvina C et al.; J Clin Eno & Metab. 2005:90(3) 1897-1899. Ott SM.
P. 323: Long term use of osteoporosis medications like Fosemax and Boniva may leade to heart attack and stroke: 

Circulation 1999;100:446-449. Goldstein MR.
P. 323: Estrogen deficiency cause osteoporosis: 

Ir J Med Sci. 2001 J-Mar;170(1):58-62. O達rien M.
P. 323: Stoping to take estrogen cause osteoporosis: 

Climacteric. 2007 Aug;10(4):273-5. Gambacciani M et al.
P. 323: Fosemax and Boniva, etc suppress (significant decrease) bone build up: 

J Clin Endo & Metab. 2005;90(3):1897-1899. Ott SM.; J Clinic Endo Metab. 2005;90(3):1294-1301. Odvina C et al.
P. 324: Magnesium help and protect the bone: 

Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Osteoporos Int. 2006;17(7):1022-32. Rude RK et al.
P. 324: Vitamin D protect the bone: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H./ Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.
P. 324: Vitamin D in high dose may increase vascular calcification: 

Circulation. 1998;98(13):1302-6. Jono S et al.
P. 324: Vitamin D strength muscle of patient with previous fractures: 

N Z Med J. 2007 Sep 21;120(1262):U2730. Inderjeeth CA et al.
P. 324: Omega 3 fish oil protect the bone: 

Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.
P. 324: Strontium is effective bone builder in spine and hips: 

Int J Clin Pract. 2007 Feb;61(2):324-8. Reginster JY et al.; Int J Clin Pract. 2007 Feb;61(2):324-8. Reginster JY et al.; Bone. 2007 May;40(5 Suppl 1):S5-8. Marie PJ.; Cochrane Database Syst Rev. 2006 Jul 19;3:CD005326. O奪onnell S et al.
P. 324: Boron has affect on bone build up: 

Biol Trace Elem Res. 1992 Dec;35(3):225-37. Nielsen FH et al.; Br J Nutr. 1993 May;69(3):871-84. Beattie JH et al.; J Clin Densi Tom. 2002 Summer;5(2)187-92. Rico H et al.
P. 324: Weight bearing exercise encouraged for building bone: 

J Ir Med Sci. 2001 Jan-Mar;170(1):58-62. O達rien M.

P. 326: Studies indicate women’s fears of breast cancer far exceed reality: 

Presentation South Atlantic Association OB/Gyn Boca Raton 2004 Levin.
P. 327: Diet and environmental exposure during pregnancy increase risk of future breast cancer: 

Trends Endocrinol Metab. 2006 Nov;17(9): 340-8. Hilakivi-Clarke L et al.
P. 327: Prenatal exposure to bisphenol (very common estrogen like chemical) induces breast cancer: 

Environ Health Perspect. 2007 Jan;115(1):80-6. Durando M et al.; Environ Health Perspect. 2007 Apr;115(4):592-8. Wadia PR et al.
P. 327: Alcohol consumption during pregnancy and risk of future breast cancer in unborn daughter: 

Br J Cancer. 2004 Jun;1;90(11): 2225-31. Hilakivi-Clarke L et al.
P. 327: High-fat diet and significant weight gain during pregnancy increase rates of breast cancer in offspring: 

Int J Cancer. 2006 Oct 1;119(7): 1537-46. De Assis S et al.
P. 327: Use of DES increases occurrence of breast cancer in unborn daughters: 

Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
P. 327: Study: adult women who have gained 55 pounds experience increased risk of breast cancer: 

JAMA. 2006 Jul 12;296(2):193-201. Eliassen AH et al.; Semin Oncol. 2006 Apr;33(2 Suppl 7):2-7. Forbes JF.
P. 328: Birth control significantly increase incidence of breast cancer, risk is much higher if oral contraceptive start at young age: 

Breast Cancer Res Treat. 1998 Jul;50(2):175-84. Ursin G et al.; J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. White E et al.; Contraception. 1996 Sep;54(3 Suppl):1S-106S.
P. 328: Teenage pregnancy decreases breast cancer for life: 

Int J Food Sci Nutr. 1995 Nov;46(4):373-81. Walker AR et al.
P. 328: Gain of more than 22 pounds since menopause increases risk of breast cancer: 

JAMA. 2006;296: 193-201. Eliassen AH et al.
P. 328: Consumption of bad fat (Omega 6) increase risk of breast cancer: 

Cancer Causes Control. 2002 Dec;13(10): 883-93. Wirfalt E et al.
P. 328: Red meat increases risk of breast cancer: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 328: More than 1.5 servings of red meat a day increases risk of breast cancer bt 97%: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 328: Increased risk of breast cancer by taking birth control between the ages of 15 and 20: 

Eur J Cancer. 2005;41(15): 2312-20. Jernstrom H et al.
P. 329: Weight and girth gain during pregnancy increases breast cancer risk: 

J Nutr. 2006 Apr;136(4): 998-1004. De Assis S et al.
P. 329: Waist hip ratio and weight gain over life time increases breast cancer risk: 

International J of Cancer. 2002;99: (3): 445-52. Friedenreich CM et al.
P. 329: Weight gain of 38 pounds during pregnancy increase breast cancer risk: 

American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
P. 329: Antibiotic treatment significantly increases risk for breast cancer: 

JAMA. 2004;291(7): 827-35. Christine M et al.
P. 329: Increased breast cancer risk due to proliferation of abnormal bacteria due to antibiotic treatment: 

Cancer Res. 2007 Feb 1;67(3): 847-50. Rao VP et al.
P. 329: Certain groups more susceptible to environmental pollutants:

 Contraception. 1996 Sep;54(3 Suppl):1S-106S.
P. 330: Study: significant stress doubles breast cancer risk: 

LA Time. Sep 24, 2002 Health section cancer Conference Copenhagen et al. Med Hypotheses. 2007;68(5):1138-43. Gago-Dominguez M et al.; Mol Cell Biochem. 2007 Aug 11; Zweitzig Dr. et al.
P. 330: Job strain increase risk of breast cancer: 

Epidemiology. 2007 Sug 30; Kuper H et al.
P. 330: Stress history increase recurrence of breast cancer: 

J Psychosom Res. 2007 Sep;63(3):233-9 Palesh O et al.
P. 330: Stress increases metastasis marker in breast cancer cell: 

Mol Cell Biochem. 2007 Aug 11; Zweitzig DR et al.
P. 330: Studies demonstrating iodine deficiency increase risk for breast cancer: 

Trans New York Acad Sciences. 1970;32: 911-47. Eskin BA.; Breast. 2001 Oct;10(5):379-82. Venturis S.; Cancer Causes Control. 2000 Feb;11(2):121-7. Cann SA et al.; Adv Exp Med Biol. 1977;91:293-304. Eskin BA.
P. 330: SSRIs like Prozac, Zolof etc. increase uncommon but aggressive type of breast cancer: 

Breast Cancer Res Treat. 2005 Dec 2;: 1-10. Chien C et al.
P. 330: It takes 15 years until 2 breast cancer cells reach size of 1 cm: 

Jpn J Cancer Res. 1990 May;81(5):454-62. Kuroishi t et al.
P. 331: Breast cancer risk drops with each pregnancy by 7%: 

LANCET. 2002;360(9328): 187-95.
P. 331: Women with breast cancer who get pregnant live longer and have less recurrences comparing to women with breast cancer that do not get pregnant: 

BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Ob. Gyn News. 2006 Jul 13: P2. Largillier R.; J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/august;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun 1;85(11):2424-32. Valentgas P et al.
P. 331: Aromatization is the process that converts testosterone to estrogen in the breast: 

J Br Med J 1998;296(6624)741-3. O’Neill JS et al.
P. 331: Inflammation with increase of TNFk, NFKbeta, IL6/IL12 and COX-2 activity promote aromatization and increase aggressiveness metastasis ability and resistance to treatment of breast cancer: 

Endocr Relat Cancer. 2005 Jul;12 Suppl 1: S37-46. Zhou Y et al.; Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; Endocrinology. 2005 Nov;146(11): 4917-25. Saitoh M et al.
P. 331: Women who have 7 or more mammograms increase breast cancer risk by 80%: 

Breast Cancer Res Treat. 2007 Jul 7; Ma H et al.
P. 331: X-ray before age 20 increase breast cancer by 40% in women with cystic breast: 

Cancer Causes Control. 2002 Oct;13(8):711-8. Hill DA et al.
P. 331: Women that have radiation as treatment for breast cancer have significant increase in heart attack incidence: 

Radiother Oncol. 2007 Mar;82(3):294-300. Paszat LF et al.
P. 331: Grapefruit intake may increase risk of breast cancer: 

Br J Cancer. 2007 Jul 10; Monroe KR et al.
P. 331: Women who where exposed to higher dose of DDT at young age has significant risk of increase breast cancer: 

Los Angeles Times, By Maria Cone. September 30 2007: Chief investigator Cohn BA.
P. 331: Indole-3-carbinol abolish negative affect of DDT on the breast: 

Acta Biochim Pol. 2007;54(1):113-7. Ociepa-Zawal M et al.
P. 331: Exposure to higher dose of DDT increases breast cancer: 

J Natl Cancer Inst. 1993 Apr 21;85(8):648-52. Wolff MS et al.
P. 331: Excessive iron increases the risk of breast cancer: 

Cancer Causes Control. 2007 Dec;18(10):1047-53. Kabat GC et al.;
P. 331: Genetic risk for increase iron level associated with increase post menopausal breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94. Hong CC et al.
P. 331: HPV virus Epstein-Bar virus and mouse mammary tumor virus may have a role in the development of cancer: 

Future Microbiol. 2006 Jun;1:33-51. Lawson JS et al.
P. 331: Oxidative stress contribute to the development of breast cancer: 

Clin Biochem. 2007 Oct;40(15):1129-34. Delimaris I et al.
P. 331: Progesterone and 17 Beta HSD 2 metabolize estradiol to estrone: 

Breast Cancer. 2006:13(2): 129-36. Sasano H et al.
P. 332: Evening primrose oil (gamma linolenic acid) enhances positive treatment result of women with Her-2/neu expression in breast cancer: 

J Natl Cancer Inst. 2005 Nov 2:97(21):1611-5. Menendez JA et al.
P. 332: Evening primrose oil (GLA) may be protecting breast cancer metastasis: 

J Cell Biochem. 2007 May 1;101(10):155-66. Martin TA et al.
P. 332: Flax seed slow breast cancer metastasis by decrease VEGFs: 

Cancer Lett. 2002 Nov 8;185(1):31-7. Dabrosin C et al.
P. 332: Flax seed inhibit breast cancer and improve tamoxifen treatment: 

Clin Cancer Res. 2004 Nov 15;10(22):7703-11. Chen J et al.
P. 332: Fish oil protects us from breast cancer: Int J Cancer. 2005 Nov 10;117(3): 

340-8. Wu M et al.; Breast Cancer Res Treat. 1995 Jun;34(3): 199-212. Chajes V et al.; Oncol Rep. 2007 Apr;17(4):713-9. Jourdan ML et al.
P. 332: Fish oil and vitamin E decrease breast cancer cell growth: 

Breast Cancer Res Treat. 1995 Jun;34(3):199-212. Chajes V et al.
P. 332: Perimenopausal women cosuming more Omega-3 and less Omega-6 less likely to develop breast cancer: 

J Nutr. 2003 May;133(5): 1409-14. Goodstine SL et al.
P. 332: CLA inhibits cell proliferation in cancer cells: 

Exp Mol Pathol. 2005 Oct;79(2): 118-25. Albright CD et al.
P. 332: Whey and whey acid proteins inhibits proliferation and spread of breast cancer: 

J Cell Physiol. 2007 May31; Nukumi N et al.; Cancer Lett. 2007 Jul 8;252(1):65-74. Nukumi et al.
P. 333: Soy and soy products decrease breast cancer and decrease breast cancer resistance to treatment: 

Oncogene. 2005 Apr 7;24(15):2558-67. Kim SO et al.; J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. Touillaud MS et al.; Cancer Res. 2004 Jun 15;64(12):4346-52. Imai Y et al.
P. 333: Consuming ginger may dcrease breast cancer resistance: 

Oncogene. 2005 Apr 7;24(15): 2558-67. Kim So et al.
P. 333: Curcumin’s anti-inflammatory and anti-tumor affect as significant protection from breast cancer: 

Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Anticancer Res. 2005 Sep-Oct;25(5): 3293-302. Ramachandran C et al.; Int J Mol Med. 2007 Sep;20(3):329-35. Poma P et al.; Cancer Res. 2007 Apr 15;67(8):3853-61. Kunnumakkara AB et al.
P. 333: Investigation of green tea as treatment for breast cancer: 

IDrugs. 2003 Nov: 6(11): 1073-8. Rosengren RJ.
P. 333: Green tea as an anti-inflammatory and COX-2 inhibitor: 

Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Int J Cancer. 2005 Feb 10;113(4): 660-9. Hussain T et al.
P. 333: Green tea decreases aggressive nature of cancer cells: 

Nutr Cancer. 2005;52(1): 66-73. Slivova V et al.
P. 333: Green tea inhibiting destructive effect of Her-2/neu and (EGFR) that are significant risk factor in breast cancer: 

Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
P. 333: Green tea enhances efficiency of Taxol: 

Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
P. 333: Taxol standard breast cancer toxic chemotherapy found not to be effective but with patients with HER2:
P. 333: Grape juice, grape seeds, and red wine as aromatase inhibitors for prevention of breast cancer: 

Ann N Y Acad Sci. 2002;963: 229-38. Chen S.; Cancer Res. 2006 Jun 1;66(11): 5960-7. Kijima I et al.; Breast Cancer Res Treat. 2001 May;67(2): 133-46. Eng ET et al.; Ann N Y Acad Sci. 2002 Jun;963: 239-46. Eng ET et al.
P. 334: Resveratrol is a COX-2 inhibitor: 

Biofactors. 2004;21(1-4): 33-9. Kundu JK et al.
P. 334: Resveratrol is a NFkB inhibitor: 

Int J Mol Med. 2006 Jun;17(6): 1069-75. Kim YA et al.
P. 334: Resveratrol regresses tumor formation: 

Arch Int Med. 1991;151: 75. Henderson BE et al.
P. 334: Resveratrol as a reason for the so-called “French Paradox”: 

Mol Nutr Food Res. 2005 May;49(5): 452-61. Ulrich S et al.
P. 334: Pomegranates decrease NFkB: 

Int J Cancer. 2005 Jan 20;113(3): 423-33. Afaq F et al.; Breast Cancer Res Treat. 2002 Feb;71(3): 203-17. Kim ND et al.
P. 334: Pomegranates decrease breast cancer cell proliferation: 

J Med Food. 2005 Winter;8(4): 469-75. Jeune MA et al.
P. 334: Pomegranate prevents breast cancer cells from developing new blood vessels and progression: 

Angiogenesis. 2003;6(2): 121-8. Toi M et al.; Eur J Cancer Prev. 2004 Aug;13(4): 345-8. Mehta R et al.
P. 335: Mushrooms that serve as a treatment option for estrogen receptor negative breast cancer: 

Oncol Rep. 2006 Feb;15(2): 417-23. Gu YH et al.
P. 335: Ganoderma lucidum mushrooms down regulate NFkB inhibit breast cancer: 

Int J Oncol. 2006 Sep;29(3): 695-703. Jiang J et al.
P. 335: White button mushroom is chemo preventive in breast cancer via anti aromatase activity: 

J Nutr. 2006 Apr;136(4):998-1004. de Assis S et al.
P. 335: Perimenopausal women consuming more than 30 grams of fiber daily decrease breast cancer: 

Int J Epidemiol 2007 Apr;36(2):431-8. Cade J et al.
P. 335: 2 Metoxyestradiol protect against breast cancer: 

Circ Res. 2006 Aug 4;99(3): 266-74. Barchiesi F et al.
P. 335: 16 Hydroxy esterone increase breast cancer risk: 

Maturitas. 2006 Apr 20;54(1): 72-7. Seeger H et al.
P. 335: Breast cancer patients have higher levels of 16 Hydroxy esterone: 

Cancer Epidemiol Biomarkers Prev. 1997;6: 505-9. Kabat GC et al.
P. 335: Breast cancer patients have lower levels of 2 Hydroxy esterone: 

Epidemiology. 2000 Nov;11(6):635-40. Muti P et al.; Epidemiology. 2006 Jan;17(1):80-8. Kabat GC et al.; Steroids. 2003 Jan;68(1):65-72. Fowke JH et al.
P. 335: DIM supplements increase 2 Hydroxy esterone and may protect from breast cancer: 

Nutr Cancer. 2004;50(2): 161-7. Dalessandri KM et al.
P. 335: Indol3 Carbinol supplements increase 2 Hydroxy esterone: 

J Cell Biochem Suppl. 1997;28-29: 111-6. Wong GY et al.; Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Oncogene. 2001 May 24;20(23): 2927-36. Chinni SR et al.
P. 335: Indol3 Carbinol reduces epidermal growth factor receptors that usually increase cancer progresion: 

Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Carcinogenesis. 2007 Feb;28(2): 435-45. Moiseeva EP et al.
P. 335: High level of 2 Hydroxyesteron associated with osteoporosis: 

J Clin Endo Meta. 2005;90(4):2035-2041. Napoli N et al.; J Bone Miner Res. 2000 Dec;15(12):2513-20. Leelawattana R et al.
P. 335: Breast cancer associated with increase bone density: 

Maturitas. 2006 Oct 16; Hadju P et al.
P. 335: Snips in 1B1 increase 4 OH estrone that increase breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3): 209-216. Goodman MT et al.; Cancer Res. 2000 Jul;60(13):3440-3444. Hanna IH et al.; Endocr Rev. 2000 Feb;21(1):40-54. Liehr JG.; Afr J Reprod Health. 2006 Apr;10(1):13-25. Okobia MN et al.
P. 335: Women with SNP in 1B1 have a 220% increase in risk of breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2000;9(2):147-150. Zheng W et al.
P. 335: DHEA suppresses production of 4 Hydroxy esterone: 

Mol Cell Biochem. 1999 Aug;198(1-2) 89-100. Ikegwuonu FI et al.
P. 335: COMT defect increases breast cancer: 

Cancer Res. 1998;58: 2107-2110. Thompson PA et al.; Cancer Res. 1999;59: 4870-4875. Huang CS et al.; Cancer Res. 1997 Dec 15;57(24):5493-7. Lavigne JA et al.
P. 335: Overweight women with COMT defect have higher risk of breast cancer: 

Cancer Res. 1998 May 15;58(10):2107-10. Thompson PA et al.; Cancer Res. 1999 Oct 1;59(19):4870-5. Huang CS et al.
P. 335 COMT defect and Folic Acid deficiency are risk for breast cancer: 

Carcinogenesis. 2001;22(10): 1661-1665. Goodman JE et al.
P. 335: GST protects from pollutants and toxins: 

Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.
P. 335: GST SNP defect increase breast cancer risk by 50%: 

Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.; J Natl Cancer Inst. 1998;90: 512-518. Helzlsouer KJ et al.
P. 335: Combination of SNPs in COMP and GST further increase breast cancer risk: 

Pharmacogenetics. 2002;12: 67-72. Mitrunen K et al.
P. 335: Uderstanding personal risk of developing breast cancer: 

Fertil Steril. 2004 Jul;82(1):132-7. Clemens B et al.
P. 335: Hope is aromatase inhibitor and may decrease breast cancer: 

J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.;
P. 336: Sulforaphane (SGS) stop breast cancer growth: 

Drug Discov Today. 2004 Nov 1;9(21):908. Johnston N.; Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Mol Cancer Ther. 2007 Mar;6(3):1013-21. Pledgie-Tracy A et al.; Mol Cells. 2005 Dec 31;20(3):364-70. Kim SJ et al.; Life Sci. 2006 May 22;78(26):3043-50. Thejass P et al.; Vascul Pharmacol. 2007 Feb;46(2):77-84. Jackson SJ et al.;
P. 335: Royal jelly inhibits growth in breast cancer cells: 

Biosci Biotechnol Biochem. 2007 Jan;71(1): 253-5. Nakaya M et al.
P. 336: Quercetin increases protection from breast cancer: 

Cancer Biol Ther. 2007 Jan 29;6(1). Dechsupa S et al.
P. 336: Selenium down-regulated estrogen Receptor Alpha expression: 

Breast Cancer Res Treat. 2005 Aug;92(3): 239-50. Shah YM et al.; J Cell Biochem. 2007 Jan 22; Martin TA et al.
P. 336: Vitamin E Tocotrienol functions as an anti-cancer mechanism in pre-cancer and cancer cells: 

Exp Biol Med. 2005 Apr;230(4): 235-41. Shah SJ et al.; Asia Pac J Clin Nutr. 2005;14(4): 366-73. Sylvester PW et al.; Ann N Y Acad Sci. 2004 Dec;1031: 143-57. Nesaretnam K et al.; Biochem Biophys Res Commun. 2006 Jul 28;346(2): 447-53. Srivastava JK et al.; Cancer Detect Prev. 2005;29(4): 383-8. Yu FL et al.
P. 337: Vitamin D decreases growth of breast cancer cells: 

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2): 103-9. Townsend K et al.; J Steroid Biochem Mol Biol. 2003 Feb;84(2-3): 149-57. Wietzke JA et al.; Oncogene. 2000 Oct 19;19(44): 5091-7. Campbell MJ et al.; Acta Pharmacol Sin. 2007 Sep;28(9):1373-82. Welsh J.
P. 337: Co-Enzyme Q10 produces complete and partial remission of breast cancer: 

Biochem Biophys Res Commun. 1994 Mar 30;199(3): 1504-8. Lockwood K et al.
P. 337: Lycopene is a suppressor of the initiation process of breast cancer: 

Pharmacogenomics. 2006 Jul;7(5): 663-72. Chalabi N et al.; Toxicol In Vitro. 2007 Mar;21(2):217-23. Fornelli et al.
P. 337: Vitamins B-12 and B-6 decrease incidence of breast cancer: 

J Natl Cancer Inst. 2003 Mar 5;95(5): 373-80. Zhang SM et al.
P. 338: Physical activity decreases the risk of invasive breast cancer: 

Cancer Epidmed Biomarkers Prev. 2007 Feb;16(12): 236-43. Sprague BL et al.
P. 338: Physical activity decrease estrogen-Positive progesterone-Negative breast cancer: 

Arch Intern Med. 2006 Dec 11-25;166(22): 2478-83. Bardia A et al.
P. 338: 1991 Harvard University study about wearing bras and increase incidence of breast cancer: 

Eur J Cancer. 1991 27: 131-5. Hsieh CC et al.
P. 339: Bra use decreases Melatonin: Chronobiol Int. 2000 Nov;176: 

783-93. Lee YA et al.
P. 339: Large bra cup sizes in young women increase risk of perimenopausal breast cancer: 

Int J Cancer. 2006 Apr 15;118(8): 2031-4. Kusano AS et al.
P. 339: Bra use for 18-24 hours per day increase breast cancer risk more than 100 fold: 

Dressed To Kill 1995. Avery Press Singer S et al.
P. 339: Stoping to use bra stop shoulder pain: 

Clin Endocrinol 2006;64(1)20-8. Enriori PJ et al.
P. 340: Study indicating that bra wear results in future breast sagging: 

J Hum. Ergol. 1990 Jun; 19(1): 53-62. Ashizawa K et al.
P. 340: Higher incidence of breast cancer in upper, outer quadrant of breast: 

J Appl Toxicol. 2003 Mar-Apr;23(2): 89-95. Darbre PD.
P. 340: Nearly everything applied to upper, outer quadrant is toxic: 

Appl Toxicol. 2003 Sep-Oct;23(5): 285-8. Harvey PW.
P. 340: Parabens has been identified in breast cancer tissue: 

J Appl Toxicol. 2005 Jul-Aug;25(4): 301-9. Pugazhendhi D et al.; J Appl Toxicol. 2004 May-Jun;24(3):167-76. Harvey PW et al.
P. 340: Aluminum in antiperspirants associated with DNA alteration: 

J Inorg Biochem. 2005 Sep;99(9): 1912-9. Darbre PD.
P. 340: Studies indicating longer use of anything on underarm, the earlier breast cancer diagnosis: 

Eur J Cancer Prev. 2003 Dec;12(6): 479-85. McGrath KG.
P. 341: Full-term pregnancy and breast feeding decrease incidence of breast cancer: 

LANCET. 2002;360(9328): 187-95.
P. 341: Pregnancy after breast cancer increase survival and decrease cancer recurrence comparing to breast cancer survivor that did not get pregnant: 

BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/August;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun1;85(11):2424-32. Velentgas P et al.; Los Angeles Times. 2007 Sept 30;UC Berkley study main investigator. Barbara A Cohn.
P. 341: Teenage pregnancy associated with decreased risk of breast cancer: 

Int J Food Sci Nutr. 1995 Nov;46(4): 373-81. Walker AR et al.
P. 341: Mice given high doses of estrogen and progesterone at puberty reduced breast cancer by 60%, and eliminated HER-2/neu (HER-2): 

Breast Cancer Res. 2007 Jan 26;9(1): R12. Rajkumar L et al.
P. 341: Breastfeeding decreases incidence of cancer by 4.3%: 

LANCET. 2002;360(9328): 187-95.
P. 341: Nipple stimulation releases duct obstruction and free-radicals and may decrease breast cancer: 

Med Hypotheses. 1991 Dec;36(4): 389-96. Murrell TG.; Breast Cancer Res Treat. 1995 Aug;35(2): 225-9. Murrell TG.
P. 342: Progesterone increases the production of oxitocyn: Breast Cancer Res Treat. 1995 Aug;35L2):

225-9. Murrell TG.
P. 342: Dhea and androgen protect from breast cancer: 

Endocrine Related Cancer. 2006;13:335-355. Labrie F.
P. 342: Dhea and androgens inhibits breast cancer: 

Endo Review. 2003;24(2)”152-182. Labroe F et al.
P. 342: Dhea decrease breast cancer proliferation: 

Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et al.
P. 342: Dhea stop progression of breast cancer: 

Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
P. 342: Dhea and androgens are chemopreventive and novel cancer anti-proliferative by multiple mechanism: 

Curr Pharm Des. 2006;12(26):3411-21. Matsuzaki Y et al.
P. 342: Dhea protect from breast cancer: 

Endo Relat Cancer. 2006 Jun;13(2):335-355. Labrie F.
P. 342: Dhea is chemoprotive against breast cancer: 

Int J Cancer. 2003 Jun 20;105(3):321-5. Ciolino H et al.
P. 342: Dhea is a treatment option to treating estrogen negative breast cancer: 

World J Surg. 2007 May;31(5);1041-6. Hardin C et al.
P. 342: Androgen and dhea has inhibitory effect on breast cancer: 

Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.
P. 342: DHEA suppresses and prevents growth of 4 Hydroxy esterone: 

C Y Mol Cell Biochem. 1999;198(1-2): 89-100. Ikeawuonu FL et al.
P. 342: DHT inhibits growth of breast cancer: 

Breast Cancer Res. 2005;7(6): R1132-40. Shilkaitis A et al.
P. 342: IGBP-3 inhibits growth of breast cancer: 

Cancer Res. 2004 Mar 15;64(6):2229-37. Kim HS et al.
P. 342: Melatonin decrease breast cancer growth: 

J Pineal Res. 2006 May;40(4): 291-6. Martinez-Campa C et al.
P. 342: Melatonin improve survival rates in animals with untreated breast cancer: 

Mol Cell Biochem. 2005 Oct;278(1-2): 15-20. Saez MC et al.
P. 342: Melatonin causes the regression of breast cancer by behaving as an aromatase inhibitor: 

Breast Cancer Res Treat. 2005 Dec;94(3): 249-54. Martinez-Campa C et al.
P. 344: Higher estriol levels in pregnancy translate to 58% reduction in future breast cancer: 

Prospective study of Estrogen during pregnancy risk of Breast Cancer; unpublished studies performed at the Public Health Institute in Oakland and funded by USA Army Medical Research. DAMD 17-99-1-9358 et al.
P. 344: Estriol (E3) protect the development of ovarian cancer: 

J Endocrinol. 2007 Jun;193(3):421-33. Treeck O et al.
P. 344: Adiponectin protects from breast cancer: 

J Clin Endocrinol Metab. 2007 Apr;92(4):1510-16. Tworoger SS et al.
P. 345: Use of bioidentical estradiol and progesterone promotes decrease in breast cancer: 

Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.; Gynecol Endocrinol. 2006 Aug;22(8):423-31. Espie M et al.
P. 345: Women with breast cancer given estrogen enjoyed higher survival rates: 

J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.; Menopause. 2003 Jul-Aug;10(4):277-85. Decker DA et al.
P. 345: Breast cancer surgery during highest level of estradiol enjoys better outcomes: 

Eur J Surg Oncol. 2001 Mar;27(2): 152-6. Holmberg L et al.
P. 345: Estrogen increases apatosis: 

J Steroid Biochem Mol Biol. 2000;72(3-4): 89-102. Szelei J et al.
P. 345: Estradiol decreases Interleukin-6: Egypt J Immunol. 2004;11(2): 

165-70. Hussein MZ et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 345: Estradiol reduces NFkB: Endocr Relat Cancer. 2006 Jun;13(2): 

607-616. Montagut C et al.; J Huazhung Univ Sci Technology Med Sci. 2006;26(1): 53-8. Wang Y et al.; Poster Endocrin Society. 2004 Page 334 P2 119. Liu H et al.; Mol Endocrinol. 2007 Oct 11; Nettles KW et al.
P. 345: Estrogen receptor positive breast cancer is less aggressive: 

J Clinc Oncol. 1998 Sep;16(9): 3115-20. Holi IC et al.
P. 345: Estrogen receptor positive has higher survivol rate: 

Neoplasma. 1993;40(1): 55-7. Heise E et al.; Int J Cancer. 1994 Nov;59(3): 351-6. Nagai MA et al.
P. 345: Estradiol binds to Estrogen Receptor Beta that decrease breast cancer growth: 

Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.
P. 345: Estrogens were common treatment against breast cancer: 

JAMA. 1997;237: 2079-85. Carter AC et al.; Endocrine Therapy In Malignant Disease. 1972;156-158. Stoll BA et al.
P. 346: When conventional treatment fails for breast cancer with anti estrogen drug, adding estrogen can make it work again: 

Breast. 2005 Sep 29. Jordan VC et al.; World J Surg Oncol. 2006 Jul 11;4: 44. Agrawal A et al.; JAMA. 1997;237: 2079-85. Carter AC et al.; Med Pediats Oncol. 1990;18: 317-20. Boyer MJ et al.
P. 346: Animals supplemented with estradiol, experienced a profound reduction in breast cancer tumor size: 

J The National Cancer Institute. 2002 Aug;94(15):1173. Jordan VK et al.; Clin Cancer Res. 2001;7:3156-65. Josleen VC et al.
P. 346: Study showing estradiol treatment decreased breast cancer and the ability of it to multiply: 

Breast Cancer Research 2007 Jan 26. Lakshmanaswamy R et al.
P. 346: Dr. Bush’s summarized 25 years and 50 reports on HRT and ERT and concluded that estrogen treatment is no risk factor for increase breast cancer: 

Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.
P. 346: Dr. Speroff professor OB/GYN of Oregon University said “HRT treatment is beneficial and make breast cancer cells more differential “: 

Menopause. 2007 Oct 8; Speroff L.
P. 347: Studies confirm reduction of cancer death with use of HRT: Am J Obstet Gyn. 2002;186: 

325-34. Nanda K et al.; Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.
P. 347: WHI study’s use of Premarin only show 23% decrease breast cancer: 

JAMA. 2002 Jul 17;288(3): 321-33. Rossouw JE et al.
P. 347: Harvard University study of use of Premarin alone shows no increase of incidence of breast cancer for 15 years: 

Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
P. 347: Harvard University study shows Premarin-only use saw increase of breast cancer only after 20 years in breast cancer: 

LANCET. 1997;350(9084): 1047-59.
P. 348: Risk associated with estrogen-only treatment is equal to risk from eating red meat five times a week: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 348: Risk of breast cancer associated with estrogen-only is equal to taking 50+ days of antibiotics—45%: 

JAMA. 2004;291(7): 827-35. Christine M et al.
P. 348: Risk associated with estrogen-only is lower than risk from gaining more than 38 pounds while pregnant: 

American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
P. 348: With family history of breast cancer, use of HRT decrease of death from breast cancer: 

Ann Inter Med. 1997;127(11): 75-78. Sellers TA et al.
P. 348 Use of HRT prior to cancer diagnosis leads to be better survival rates and decrease of metastasis: 

Br J Cancer. 1999 Jul;80(9): 1453-8. Jernstrom H et al.
P. 348: Use of HRT with breast cancer survivor decrease by 50% cancer recurrence comparing to breast cancer survivors that did not take HRT: 

Women’s Health. 2001 Oct. Desala PJ.; J Reprod Med 2004 Jul;49(7):510-26. Levgur M.
P. 348: Study showing women with breast cancer treated with estrogen had higher survival rates: 

J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.
P. 348: Additional studies showing increased survival rates with use of estrogen in breast cancer survivors: 

J Natl cancer Inst. 2005 Apr 6;97(7):533-5. Von Schoultz E et al.; Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.; Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.
P. 349: study finding estrogen use in breast cancer survivors did not increase the breast cancer recurrence: 

J Natl Cancer Inst 2005;97(7)533-5. Von Schoultz E et al.
P. 349: Use of HRT to early breast cancer survivor with follow up of more than 30 years show no increase in incidence and recurrence of breast cancer: 

Am J Obstet Gynecol. 2002 Aug;187(2):289-94. Natrajan PK et al.; Obstet Gynecol. 2007 Jun;109(6):1455. Harkins T.
P. 349: Studies confirming increased survival decrease recurrence of cancer with estrogen use in breast cancer survival: 

Amer J OBGyn. 2002 Aug;187(2): 289-94. Puthugramam K et al.; Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
P. 349: Women with breast cancer treated with estrogen has higher survival and decrease recurrence comparing to group of breast cancer survivors not taking estrogen: 

Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
P. 349: Study showing bioidentical estradiol and progesterone caused a 10% reduction in breast cancer incidence compared to nonusers: 

Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.
P. 349: French study of bioidentical estradiol and progesterone showed decrease breast cancer in user comparing to non user: 

Gynecol Endocrinol. 2006 Aug;22(8): 423-31. Espie M et al.
P. 349: Mice with breast similar to women breast treated with bioidentical hormones showed significant reduction in breast cancer formation and progession: 

Breast Cancer Res. 2007;9(2):102. Rajku MAR et al.
P. 349: The fact that use of bioidentical hormones may prevent breast cancer got notice and positive suggestions: 

Breast cancer Res. 2007;9(2):102. Jerry DJ
P. 349: Estrogen preventive effect on the breast may be blocked by metabolite of cholesterol 27-Hydroxycholesterol: 

Mol Endocrinol. 2007 Sep 13; Dusell CD et al..
P. 349: WHI study warnings: 

Ob.Gyn. News. 2007 Jan 1;42(1): 1. Jancin B et al.
P. 349: Dr. Leon Speroff’s speaking publicly about problems with WHI study, “…diagnostic and selection biases…”: 

Ob Gyn News October 1, 2006. Dixon BK.
P. 349: The world is embracing the use of estrogen and progesterone and emphasizing the safety of natural hormones comparing to the chemicalize hormones: 

Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.; Bull Cancer. 2007 May 1;94(5):469-75. Czernichow C et al.; Med J Aust. 2007 Jun 18;186(12):643-6. MacLennan AH.